Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	DDX12P CHAF1A NOC3L ASH1L E2F4 TSPYL6 MLLT10 NR3C1 RUNX2 ADNP SARNP TGIF1 MSH6 PARP1 NFATC1 SETSIP POLQ OBI1 CRTC2	5.51e-05	739	184	19	GO:0003682
GeneOntologyMolecularFunction	GTPase binding	RGPD4 DMXL2 CDC42EP4 PPP1R9A RAB11FIP2 DAPK3 PQBP1 IQGAP1 VPS9D1 RGPD3 AKAP13 FGD3	1.33e-04	360	184	12	GO:0051020
GeneOntologyMolecularFunction	NAD DNA ADP-ribosyltransferase activity	PARP3 PARP1	2.52e-04	3	184	2	GO:0140294
HumanPheno	Abnormality of upper lip vermillion	TLK2 DDX59 HIVEP2 MAP1B USP9X RNF135 TRPS1 ADNP PQBP1 TRRAP TGIF1 SETD5 MYO18B PIGO MED13 CDON	1.07e-05	464	53	16	HP:0011339
HumanPheno	Abnormality of the philtrum	DDX59 HIVEP2 MAP1B USP9X RNF135 TRPS1 ASH1L RUNX2 ADNP PQBP1 TRRAP TGIF1 NBAS ARVCF SETD5 MYO18B PIGO MED13 CDON SON	1.80e-05	726	53	20	HP:0000288
HumanPheno	Thin vermilion border	TLK2 DDX59 HIVEP2 USP9X RNF135 TRPS1 RUNX2 ADNP PQBP1 TRRAP NBAS SETD5 MYO18B MED13 SON	2.09e-05	433	53	15	HP:0000233
HumanPheno	Chronic constipation	HIVEP2 USP9X ASH1L ADNP OPA1 DDOST SETD5 MED13	2.74e-05	120	53	8	HP:0012450
HumanPheno	Constipation	TLK2 HIVEP2 USP9X ASH1L LAMA3 ADNP OPA1 DDOST TGIF1 DACT1 MSH6 ARVCF SETD5 MED13 CDON	5.79e-05	472	53	15	HP:0002019
Domain	DAPK1	DAPK2 DAPK1 DAPK3	8.95e-07	3	181	3	IPR020676
Domain	ENTH	EPN3 SNAP91 CLINT1	7.20e-05	9	181	3	PS50942
Domain	ENTH	EPN3 SNAP91 CLINT1	7.20e-05	9	181	3	SM00273
Domain	ENTH	EPN3 SNAP91 CLINT1	1.02e-04	10	181	3	IPR013809
Domain	WGR	PARP3 PARP1	2.78e-04	3	181	2	SM00773
Domain	PARP_reg	PARP3 PARP1	2.78e-04	3	181	2	PF02877
Domain	WGR	PARP3 PARP1	2.78e-04	3	181	2	PF05406
Domain	-	PARP3 PARP1	2.78e-04	3	181	2	2.20.140.10
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NES SYNRG LIMA1 HIVEP2 ABL2 CDC42EP4 MAP1B DSP DAPK2 CARMIL1 RAB11FIP2 BACH1 RALGAPB DAPK3 PARD3B RICTOR MAST2 NCKAP5L LYST CDC14A PTPN13 TBC1D1 AKAP13 CLINT1 CRYBG3 OBI1 CRTC2	1.88e-13	861	187	27	36931259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RGPD4 TLK2 NES DMXL2 LIMA1 MIA3 FXR2 ZNF618 USP9X PPP1R9A DLGAP5 DAPK1 DAPK3 PPFIA3 ADNP OPA1 IQGAP1 PARP1 PTPRD SNAP91 ARVCF RGPD3 NOP2 PROX1	4.99e-10	963	187	24	28671696
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TLK2 SYNRG LIMA1 DSP CARMIL1 CHAF1A DLGAP5 BACH1 RALGAPB RICTOR TRRAP IQGAP1 PITPNM1 MSH6 ZNF644 OGA NOP2 CLUH MED13 MRTFA SON	1.48e-09	774	187	21	15302935
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MIA3 GOPC DSP USP9X PPP1R9A TRPS1 RALGAPB NOC3L DAPK3 RICTOR PPFIA3 PQBP1 NCKAP5L CDCA8 CDC14A OPA1 DDOST MSH6 PARP1 PTPN13 PTPRD ARVCF CLINT1 CRYBG3	2.68e-09	1049	187	24	27880917
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TRPM4 ENDOD1 CPAMD8 MIA3 HIVEP2 MAP1B STXBP5L CARMIL1 PPP1R9A TRPS1 RALGAPB ASH1L LAMA3 PARD3B ZNF385B ZNF385A TRRAP TASOR2 HIVEP3 ANKRD44 PTPN13 MRTFB UBE2J2 NFATC1 SETD5 TBC1D1 AKAP13 ZRANB1	8.45e-09	1489	187	28	28611215
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	A2M DMXL2 MIA3 MAP1B RALGAPB ANGEL1 RICTOR NR3C1 MAST2 DDOST ARAP3 ARVCF SUPV3L1 NOM1 AKAP13 CRYBG3 ZC3H7B CRTC2	1.72e-08	650	187	18	38777146
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	LCORL ZNF180 TRPS1 BACH1 ASH1L E2F4 ZNF385A MLLT10 NR3C1 RUNX2 SARNP HIVEP3 TGIF1 MSH6 OVOL1 NFATC1 ZNF644 PLAG1 CREB3L3 MRTFA	1.72e-08	808	187	20	20412781
Pubmed	A census of human transcription factors: function, expression and evolution.	ZBTB38 HIVEP2 LCORL ZNF180 TRPS1 BACH1 NOC3L ASH1L E2F4 ZNF385A NR3C1 RUNX2 ADNP HIVEP3 TGIF1 NFATC1 ZNF644 PLAG1 CREB3L3 ZNF541 PROX1	2.37e-08	908	187	21	19274049
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EPN3 TRPM4 SYNRG CRYBG2 HIVEP2 ATP13A1 MLLT10 LARS2 MAST2 TRRAP LYST HIVEP3 DACT1 OVOL1 ARAP3 NFATC1 ARVCF SETD5 SNX8 PCNX1 AKAP13 ZC3H7B MED13	3.36e-08	1105	187	23	35748872
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	TLK2 ENDOD1 DDX59 ATP13A1 USP9X CHAF1A RALGAPB RICTOR E2F4 DCLRE1B PQBP1 TRRAP DDOST TGIF1 NBAS RNF214 MSH6 PARP1 UBE2J2 UCP1 OGA NOP2 ZRANB1 OBI1 MED13	5.58e-08	1327	187	25	32694731
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RGPD4 MAP9 LIMA1 MAP1B DSP PCDHGA2 CHAF1A PPP1R9A NOC3L ASH1L FAM98B MINDY2 LYST TASOR2 IQGAP1 PARP1 STS SNAP91 SETSIP SETD5 PCDHGA12 RGPD3 POLQ OBI1 MED13 ZNF541	7.00e-08	1442	187	26	35575683
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RGPD4 LCORL DSP TRPS1 TNIP1 ADNP PTPN13 MRTFB ZNF644 RGPD3 CRYBG3 OBI1 MRTFA PROX1	7.16e-08	418	187	14	34709266
Pubmed	The death-associated protein kinases: structure, function, and beyond.	DAPK2 DAPK1 DAPK3	1.53e-07	3	187	3	16756490
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	TLK2 DSP FXR2 USP9X CHAF1A PARP3 RAB11FIP2 FAM98B MAST2 TRRAP OPA1 DDOST IQGAP1 TGIF1 MSH6 NOM1 PIP5K1B SERINC3 AKAP13 POLQ OBI1 CRTC2 SON	4.79e-07	1284	187	23	17353931
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	LIMA1 MIA3 USP9X PPP1R9A RAB11FIP2 RALGAPB RICTOR MAST2 NCKAP5L ANKRD44 PTPN13 TBC1D1 CRTC2	1.02e-06	446	187	13	24255178
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SCFD2 DMXL2 MIA3 GOPC SYNM ATP13A1 BACH1 RALGAPB NOC3L TNIP1 RICTOR NR3C1 NCKAP5L GRSF1 DDOST NBAS PARP1 PTPN13 ZNF644 AKAP13 CRYBG3 OGA NOP2 CLUH	1.66e-06	1487	187	24	33957083
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ABL2 USP9X TRPS1 LARS2 PARP1 SETD5 SNX8 PLAG1 ZNF518B NOP2 SON	2.08e-06	332	187	11	37433992
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	A2M CDSN LIMA1 DSP COL5A3 PPFIA3 OPA1 IQGAP1 MSH6 PARP1 CLINT1 NOP2 SON	2.13e-06	477	187	13	31300519
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	RGPD4 MAP1B TRPS1 RICTOR PARP1 NOM1 RGPD3 OGA OBI1	2.73e-06	215	187	9	35973513
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	GOPC FXR2 ZNF618 CHAF1A TRPS1 ANGEL1 ASH1L RICTOR PPFIA3 MAST2 NCKAP5L TRRAP OPA1 MSH6 SETSIP SETD5 CRYBG3 SEZ6L SON PROX1	2.80e-06	1116	187	20	31753913
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	TLK2 ENDOD1 LIMA1 GOPC CARMIL1 RAB11FIP2 BACH1 E2F4 PQBP1 SARNP NCKAP5L OPA1 IQGAP1 USP21 RNF214 PTPN13 SETD5 TBC1D1 CLINT1 NOPCHAP1 CLUH CRTC2	2.83e-06	1321	187	22	27173435
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NES FN1 MAP1B DSP FXR2 USP9X NOC3L ADNP TRRAP TASOR2 IQGAP1 MSH6 NOP2 CLUH SON	2.85e-06	653	187	15	22586326
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SYNRG LIMA1 MAP1B DSP CARMIL1 DLGAP5 NOC3L NR3C1 ADNP MSH6 PARP1 PTPN13 MRTFB CLINT1 NOPCHAP1 OGA NOP2 SON	3.36e-06	934	187	18	33916271
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ABL2 CDC42EP4 GOPC CARMIL1 PPP1R9A RAB11FIP2 RALGAPB PARD3B RICTOR OPA1 PTPN13 ARVCF	3.36e-06	421	187	12	36976175
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	RGPD4 SYNRG DMXL2 MIA3 KCNH7 GOPC MAP1B DSP FXR2 ATP13A1 STXBP5L USP9X RAB11FIP2 BACH1 RICTOR PPFIA3 OPA1 PITPNM1 RGPD3 CRYBG3	3.80e-06	1139	187	20	36417873
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MAP1B FXR2 NOC3L SARNP TRRAP CDCA8 GRSF1 DDOST IQGAP1 MSH6 NOM1 ZC3H7B NOP2 ZRANB1 DDX28 SON	3.94e-06	759	187	16	35915203
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DMXL2 RALGAPB TNIP1 PPFIA3 MRTFB TBC1D1 PCNX1 OGA MRTFA	3.96e-06	225	187	9	12168954
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SYNRG MIA3 ABL2 DSP FXR2 CARMIL1 RNF135 NOC3L PARD3B MAST2 NCKAP5L IQGAP1 MRTFB TBC1D1 ARHGAP29 CLINT1 BORA	4.09e-06	853	187	17	28718761
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	HIVEP2 MAP1B LARS2 MAST2 PTPN13 ZNF644 AKAP13 SON BORA	5.08e-06	232	187	9	25515538
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	MIA3 DDX59 FXR2 USP9X NOC3L RICTOR ADNP SARNP TRRAP MSH6 PARP1 NOP2	5.26e-06	440	187	12	34244565
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TRPM4 ATP13A1 CHAF1A PPP1R9A TRPS1 RALGAPB NOC3L RICTOR ZNF385A PQBP1 TRRAP GRSF1 IQGAP1 MSH6 PTPN13 MRTFB SETD5 NOM1 RGPD3 ZC3H7B MED13 DDX28 SON	6.26e-06	1497	187	23	31527615
Pubmed	Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size.	ILRUN ZBTB38 LCORL PLAG1	6.62e-06	23	187	4	19343178
Pubmed	EpsinR: an AP1/clathrin interacting protein involved in vesicle trafficking.	SYNRG SNAP91 CLINT1	1.25e-05	9	187	3	12538641
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	DMXL2 DAPK2 CARMIL1 RALGAPB MAST2 TRRAP CDCA8 GRSF1 USP21 PITPNM1 NEK3 PTPRD ARVCF SETD5 SUPV3L1 NOM1 SNX8 SERINC3 PLD5 ZRANB1	1.35e-05	1242	187	20	30973865
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	NES CDSN FN1 MAP1B DSP DLGAP5 NOC3L RICTOR ADNP TRRAP GRSF1 DDOST IQGAP1 MSH6 PARP1 ARAP3 ARVCF SUPV3L1 AKAP13 NOP2 SON	1.40e-05	1353	187	21	29467282
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	MAP1B DSP CHAF1A DLGAP5 NOC3L FAM98B ADNP PQBP1 SARNP CDCA8 TASOR2 PARP1 SNAP91 ZNF644 CLINT1 NOP2 SON	1.74e-05	954	187	17	36373674
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	LIMA1 DSP DLGAP5 NOC3L CDCA8 MSH6 NOP2 SON	1.96e-05	210	187	8	16565220
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	SYNRG DSP USP9X ZNF180 TNIP1 NR3C1 PQBP1 NCKAP5L MRTFB NFATC1 ZNF644 CRYBG3 OBI1	1.99e-05	588	187	13	38580884
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	USP9X CHAF1A DLGAP5 BACH1 TNIP1 IQGAP1 MSH6 AKAP13 NOP2 OBI1 MRTFA SON	1.99e-05	503	187	12	16964243
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	CDC42EP4 FN1 GOPC SYNM ANGEL1 NOC3L MUC16 RICTOR GRSF1 TASOR2 PTPN13 NOM1 CLINT1 NOP2 CDON	2.23e-05	777	187	15	35844135
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	HIVEP2 FXR2 CHAF1A ZNF180 TRPS1 BACH1 ASH1L E2F4 MLLT10 NR3C1 RUNX2 PQBP1 PARP1 MRTFA DNMT3L PROX1	2.34e-05	877	187	16	20211142
Pubmed	Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter.	NR3C1 NFATC1	2.88e-05	2	187	2	10623828
Pubmed	Ser289 phosphorylation activates both DAPK1 and DAPK2 but in response to different intracellular signaling pathways.	DAPK2 DAPK1	2.88e-05	2	187	2	31116076
Pubmed	Human phosphatase CDC14A regulates actin organization through dephosphorylation of epithelial protein lost in neoplasm.	LIMA1 CDC14A	2.88e-05	2	187	2	28465438
Pubmed	Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells.	DAPK2 DAPK1	2.88e-05	2	187	2	22160140
Pubmed	The phosphorylation of hCDC14A modulated by ZIPK regulates autophagy of murine pancreatic islet β-TC3 cells upon glucose stimulation.	DAPK3 CDC14A	2.88e-05	2	187	2	33090408
Pubmed	Control of bone resorption in mice by Schnurri-3.	HIVEP3 NFATC1	2.88e-05	2	187	2	22573816
Pubmed	Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.	MUC16 MSLN	2.88e-05	2	187	2	17067392
Pubmed	The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress.	TNC MRTFA	2.88e-05	2	187	2	21705668
Pubmed	Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2.	DAPK2 DAPK1	2.88e-05	2	187	2	18535204
Pubmed	A binding domain on mesothelin for CA125/MUC16.	MUC16 MSLN	2.88e-05	2	187	2	19075018
Pubmed	PARP-3 localizes preferentially to the daughter centriole and interferes with the G1/S cell cycle progression.	PARP3 PARP1	2.88e-05	2	187	2	12640039
Pubmed	Staphylococcal superantigen-like protein 8 (SSL8) binds to tenascin C and inhibits tenascin C-fibronectin interaction and cell motility of keratinocytes.	FN1 TNC	2.88e-05	2	187	2	23485472
Pubmed	Uncoupling of growth plate maturation and bone formation in mice lacking both Schnurri-2 and Schnurri-3.	HIVEP2 HIVEP3	2.88e-05	2	187	2	20404140
Pubmed	Counterbalancing anti-adhesive effects of Tenascin-C through fibronectin expression in endothelial cells.	FN1 TNC	2.88e-05	2	187	2	28986537
Pubmed	Myocardin related transcription factors are required for coordinated cell cycle progression.	MRTFB MRTFA	2.88e-05	2	187	2	23656782
Pubmed	Clinicopathological Impact of Gene Polymorphism of Nephrin and Glucocorticoid Receptor Genes in Egyptian Children with Nonfamilial Nephrotic Syndrome.	NPHS1 NR3C1	2.88e-05	2	187	2	35946274
Pubmed	Nestin modulates glucocorticoid receptor function by cytoplasmic anchoring.	NES NR3C1	2.88e-05	2	187	2	19562035
Pubmed	MRTF-A/B suppress the oncogenic properties of v-ras- and v-src-mediated transformants.	MRTFB MRTFA	2.88e-05	2	187	2	20338973
Pubmed	Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence.	MRTFB MRTFA	2.88e-05	2	187	2	23853104
Pubmed	Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis.	TNIP1 IL23A	2.88e-05	2	187	2	21623003
Pubmed	The MRTF-A/B function as oncogenes in pancreatic cancer.	MRTFB MRTFA	2.88e-05	2	187	2	26498848
Pubmed	Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.	MRTFB MRTFA	2.88e-05	2	187	2	12944485
Pubmed	Myocardin-related transcription factors are required for skeletal muscle development.	MRTFB MRTFA	2.88e-05	2	187	2	27385017
Pubmed	Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C.	FN1 TNC	2.88e-05	2	187	2	23313574
Pubmed	Parp3 promotes long-range end joining in murine cells.	PARP3 PARP1	2.88e-05	2	187	2	30213852
Pubmed	Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis.	FN1 TNC	2.88e-05	2	187	2	20708078
Pubmed	Myocardin-related transcription factors are required for cardiac development and function.	MRTFB MRTFA	2.88e-05	2	187	2	26386146
Pubmed	A novel GTPase-activating protein for Rho interacts with a PDZ domain of the protein-tyrosine phosphatase PTPL1.	PTPN13 ARHGAP29	2.88e-05	2	187	2	9305890
Pubmed	IQGAP1 regulates actin cytoskeleton organization in podocytes through interaction with nephrin.	NPHS1 IQGAP1	2.88e-05	2	187	2	25652011
Pubmed	Binding of tenascin-C to soluble fibronectin and matrix fibrils.	FN1 TNC	2.88e-05	2	187	2	7499434
Pubmed	Control of mesenchymal lineage progression by microRNAs targeting skeletal gene regulators Trps1 and Runx2.	TRPS1 RUNX2	2.88e-05	2	187	2	22544738
Pubmed	Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma.	MUC16 MSLN	2.88e-05	2	187	2	21775916
Pubmed	Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining.	PARP1 POLQ	2.88e-05	2	187	2	33911081
Pubmed	Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer.	MUC16 MSLN	2.88e-05	2	187	2	25197000
Pubmed	Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma.	FN1 TNC	2.88e-05	2	187	2	30451798
Pubmed	Reorganization of the actin cytoskeleton via transcriptional regulation of cytoskeletal/focal adhesion genes by myocardin-related transcription factors (MRTFs/MAL/MKLs).	MRTFB MRTFA	2.88e-05	2	187	2	17714703
Pubmed	Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes.	NR3C1 TRIM63	2.88e-05	2	187	2	18615595
Pubmed	Cleft palate formation in fetal Br mice with midfacial retrusion: tenascin, fibronectin, laminin, and type IV collagen immunolocalization.	FN1 TNC	2.88e-05	2	187	2	9482226
Pubmed	Divergent Regulation of Actin Dynamics and Megakaryoblastic Leukemia-1 and -2 (Mkl1/2) by cAMP in Endothelial and Smooth Muscle Cells.	MRTFB MRTFA	2.88e-05	2	187	2	28623279
Pubmed	Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?	MUC16 MSLN	2.88e-05	2	187	2	23357461
Pubmed	Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma.	MUC16 MSLN	2.88e-05	2	187	2	32468249
Pubmed	Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis.	MUC16 MSLN	2.88e-05	2	187	2	33832498
Pubmed	De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.	FN1 TNC	2.88e-05	2	187	2	24792713
Pubmed	Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides.	CHAF1A PARP1	2.88e-05	2	187	2	33098490
Pubmed	Synaptic localisation of SRF coactivators, MKL1 and MKL2, and their role in dendritic spine morphology.	MRTFB MRTFA	2.88e-05	2	187	2	29335431
Pubmed	PARP1 Hinders Histone H2B Occupancy at the NFATc1 Promoter to Restrain Osteoclast Differentiation.	PARP1 NFATC1	2.88e-05	2	187	2	31793068
Pubmed	Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties.	HIVEP2 HIVEP3	2.88e-05	2	187	2	2247438
Pubmed	DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing.	MAP1B DAPK1	2.88e-05	2	187	2	18195017
Pubmed	Mutations in CPAMD8 Cause a Unique Form of Autosomal-Recessive Anterior Segment Dysgenesis.	A2M CPAMD8	2.88e-05	2	187	2	27839872
Pubmed	The Correct Localization of Borealin in Midbody during Cytokinesis Depends on IQGAP1.	CDCA8 IQGAP1	2.88e-05	2	187	2	32685508
Pubmed	Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.	FN1 TNC	2.88e-05	2	187	2	20232238
Pubmed	Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma.	MUC16 MSLN	2.88e-05	2	187	2	22320398
Pubmed	Zipper-interacting protein kinase interacts with human cell division cycle 14A phosphatase.	DAPK3 CDC14A	2.88e-05	2	187	2	25503649
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	A2M FN1 TNC TRPS1 NR3C1 MAST2 PQBP1 SNAP91 CLINT1 OBI1	2.99e-05	363	187	10	14691545
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	MAP9 LIMA1 MAP1B ARVCF SH2D7	3.14e-05	67	187	5	29254152
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NES MAP9 DMXL2 LIMA1 FN1 MAP1B DSP TNC USP9X CARMIL1 PPP1R9A DAPK1 DAPK3 FAM98B PPFIA3 OPA1 IQGAP1 PITPNM1 PARP1 SNAP91 ARVCF	3.19e-05	1431	187	21	37142655
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ABL2 MAP1B DSP USP9X CARMIL1 RICTOR OPA1 DDOST IQGAP1 PARP1 PTPN13 ARHGAP29 CLINT1 CRYBG3	3.25e-05	708	187	14	39231216
Pubmed	Transcription factor FOXP2 is a flow-induced regulator of collecting lymphatic vessels.	FN1 NFATC1 PROX1	3.25e-05	12	187	3	33934370
Pubmed	Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation.	GOPC PPP1R9A PARD3B MAST2	3.31e-05	34	187	4	30726710
Interaction	YWHAH interactions	NES SYNRG LIMA1 HIVEP2 ABL2 CDC42EP4 FN1 DSP FXR2 CARMIL1 RAB11FIP2 RALGAPB DAPK3 PARD3B RICTOR NR3C1 MAST2 NCKAP5L LYST CDC14A IQGAP1 USP21 PTPN13 TBC1D1 AKAP13 CLINT1 CRYBG3 ZRANB1 CRTC2	2.58e-07	1102	184	29	int:YWHAH
Interaction	TOP3B interactions	EPN3 TRPM4 SYNRG CRYBG2 LIMA1 HIVEP2 FXR2 ATP13A1 PPP1R9A MLLT10 LARS2 MAST2 TRRAP LYST CDC14A GRSF1 IQGAP1 HIVEP3 DACT1 OVOL1 ARAP3 NFATC1 ARVCF SETD5 SNX8 PCNX1 AKAP13 ZC3H7B OGA NOP2 MED13 DDX28	3.65e-06	1470	184	32	int:TOP3B
Interaction	PTPRB interactions	GOPC TNC NOC3L LAMA3 PTPN13 ZRANB1	6.84e-06	51	184	6	int:PTPRB
Interaction	CLTB interactions	NES SYNRG LIMA1 MIA3 FN1 TNIP1 NR3C1 PQBP1 IQGAP1 CLINT1	8.02e-06	185	184	10	int:CLTB
Interaction	YWHAG interactions	SYNRG LIMA1 HIVEP2 ABL2 FN1 DSP CARMIL1 CHAF1A RAB11FIP2 RALGAPB DAPK3 PARD3B RICTOR MAST2 NCKAP5L TRRAP LYST CDC14A IQGAP1 USP21 PTPN13 TBC1D1 ARHGAP29 AKAP13 CLINT1 ZRANB1 CRTC2 SON	9.27e-06	1248	184	28	int:YWHAG
Interaction	RTKN interactions	LIMA1 GOPC RAB11FIP2 USP21 PARP1 PTPN13 AKAP13 ZRANB1	1.07e-05	115	184	8	int:RTKN
Interaction	YWHAB interactions	SYNRG LIMA1 ABL2 FN1 CHAF1A RAB11FIP2 RALGAPB DAPK1 DAPK3 PARD3B RICTOR MAST2 NCKAP5L TRRAP LYST CDC14A IQGAP1 DACT1 PTPN13 TBC1D1 AKAP13 ZRANB1 CRTC2 SON	1.83e-05	1014	184	24	int:YWHAB
Interaction	YWHAZ interactions	TLK2 SYNRG DMXL2 CDSN LIMA1 HIVEP2 ABL2 FN1 COL6A6 CHAF1A RAB11FIP2 RALGAPB PARD3B TNIP1 RICTOR PPFIA3 MAST2 NCKAP5L LYST CDC14A USP21 PTPN13 TBC1D1 ZNF644 ARHGAP29 AKAP13 ZRANB1 CRTC2	2.54e-05	1319	184	28	int:YWHAZ
Interaction	YWHAQ interactions	SYNRG CDSN LIMA1 ZBTB38 HIVEP2 ABL2 FN1 CHAF1A RAB11FIP2 DAPK1 DAPK3 PARD3B RICTOR LARS2 MAST2 NCKAP5L LYST CDC14A IQGAP1 PTPN13 NFATC1 TBC1D1 AKAP13 ZRANB1 CRTC2	3.11e-05	1118	184	25	int:YWHAQ
Interaction	EPS15 interactions	EPN3 LIMA1 FN1 RAB11FIP2 DLGAP5 MLLT10 IQGAP1 SNAP91 CLINT1 ZRANB1	3.59e-05	220	184	10	int:EPS15
Interaction	RGPD4 interactions	RGPD4 RICTOR RGPD3 ZRANB1	4.33e-05	22	184	4	int:RGPD4
Interaction	TCF7 interactions	FN1 NR3C1 USP21 ZRANB1	5.20e-05	23	184	4	int:TCF7
Interaction	PRP4K interactions	PARD3B TNIP1 RICTOR E2F4 NR3C1 GRSF1 MSH6 PARP1 ARHGAP29 AKAP13 ZRANB1 CLUH	5.22e-05	329	184	12	int:PRP4K
Interaction	SVIL interactions	NES LIMA1 LAMA3 DAPK1 TNIP1 RICTOR NR3C1 IQGAP1 PARP1 MRTFB	5.82e-05	233	184	10	int:SVIL
Interaction	BAG2 interactions	ILRUN ZBTB38 ABL2 FN1 MAP1B DLGAP5 DAPK1 TNIP1 RICTOR E2F4 NR3C1 ADNP RNF214 MRTFB ZRANB1 OBI1 MRTFA	5.89e-05	622	184	17	int:BAG2
Interaction	SIRT6 interactions	MIA3 DDX59 DSP FXR2 USP9X NOC3L RICTOR ADNP SARNP TRRAP PCDH20 TASOR2 MSH6 PARP1 ZNF644 NOP2 ZRANB1	6.63e-05	628	184	17	int:SIRT6
Interaction	PFN1 interactions	SYNRG MAP9 FN1 CARMIL1 RALGAPB TNIP1 MLLT10 NBAS PARP1 ARHGAP29 AKAP13 CRYBG3 ZRANB1 ZNF541 MRTFA	7.08e-05	509	184	15	int:PFN1
Interaction	YWHAE interactions	EPN3 SYNRG LIMA1 HIVEP2 ABL2 FN1 MAP1B CHAF1A RAB11FIP2 RALGAPB DAPK3 PARD3B TNIP1 RICTOR MAST2 NCKAP5L LYST CDC14A IQGAP1 USP21 VPS9D1 PTPN13 TBC1D1 AKAP13 ZRANB1 CRTC2	7.74e-05	1256	184	26	int:YWHAE
Interaction	MAFF interactions	BACH1 NR3C1 PARP1 OVOL1 ZRANB1	8.27e-05	49	184	5	int:MAFF
Interaction	RGPD1 interactions	RGPD4 DLGAP5 RICTOR NR3C1 RGPD3	8.27e-05	49	184	5	int:RGPD1
Interaction	NEK3 interactions	CDCA8 PARP1 NEK3 SON	8.59e-05	26	184	4	int:NEK3
Interaction	LRIF1 interactions	TLK2 CRYBG2 CHAF1A NR3C1 ADNP PQBP1 TGIF1 PARP1 ZNF644 ZRANB1	9.46e-05	247	184	10	int:LRIF1
Interaction	CASP14 interactions	CDSN FN1 DSP TNIP1 RICTOR UBE2J2 ARHGAP29 ZRANB1	9.52e-05	156	184	8	int:CASP14
Interaction	CLTA interactions	CCDC91 NES SYNRG LIMA1 MIA3 FN1 TNIP1 NR3C1 IQGAP1 MRTFB CLINT1 ZRANB1	9.67e-05	351	184	12	int:CLTA
Interaction	AP2A1 interactions	LIMA1 FN1 RAB11FIP2 TNIP1 RICTOR E2F4 CDC14A IQGAP1 PARP1 CLINT1 ZRANB1	9.96e-05	299	184	11	int:AP2A1
Interaction	CENPV interactions	TNIP1 NR3C1 GRSF1 PARP1 CCT8L2 NOP2 ZRANB1	1.24e-04	121	184	7	int:CENPV
Interaction	LIG3 interactions	TNIP1 NR3C1 LARS2 TRRAP PARP1 CCT8L2 NFATC1 ZRANB1 CLUH	1.24e-04	207	184	9	int:LIG3
Interaction	TCERG1 interactions	ZBTB38 FN1 CHAF1A TNIP1 RICTOR E2F4 POLQ ZRANB1 CLUH	1.24e-04	207	184	9	int:TCERG1
Interaction	EED interactions	LIMA1 FN1 MAP1B DSP FXR2 USP9X BACH1 NOC3L DAPK1 RICTOR ADNP TRRAP DDOST TASOR2 IQGAP1 USP21 MSH6 PARP1 STS NOM1 SNX8 TRIM63 CLINT1 NOP2 ZRANB1 CLUH DNMT3L SON	1.24e-04	1445	184	28	int:EED
Interaction	FMR1 interactions	MIA3 MAP1B FXR2 USP9X DAPK3 TNIP1 E2F4 NR3C1 PQBP1 TRRAP GRSF1 IQGAP1 RNF214 ZC3H7B ZRANB1	1.25e-04	536	184	15	int:FMR1
Interaction	HMGA1 interactions	FN1 DSP USP9X CHAF1A TNIP1 E2F4 SARNP GRSF1 RNF214 PARP1 NFATC1 ZNF644 ZRANB1	1.31e-04	419	184	13	int:HMGA1
Interaction	EIF2S3B interactions	TNIP1 TRRAP CDC14A NOP2	1.34e-04	29	184	4	int:EIF2S3B
Interaction	KCTD3 interactions	EPN3 LIMA1 RAB11FIP2 IQGAP1 USP21 PTPN13 TBC1D1 CRTC2	1.35e-04	164	184	8	int:KCTD3
Interaction	VARS1 interactions	FN1 MAP1B USP9X TNIP1 RICTOR FAM98B ADNP CDCA8 IQGAP1 ZRANB1	1.44e-04	260	184	10	int:VARS1
Interaction	KDM1A interactions	LCORL DSP USP9X CHAF1A RNF135 TRPS1 TNIP1 E2F4 NR3C1 ADNP TRRAP MSH6 PTPN13 MRTFB ZNF644 ARHGAP29 CRYBG3 ZRANB1 OBI1 MRTFA PROX1	1.45e-04	941	184	21	int:KDM1A
Interaction	DAPK3 interactions	LIMA1 DAPK3 CDC14A OPA1 IQGAP1 ZRANB1	1.66e-04	89	184	6	int:DAPK3
Interaction	ATP5F1D interactions	E2F4 NR3C1 LARS2 GRSF1 DDOST SGCZ TRIM63 ZRANB1	1.66e-04	169	184	8	int:ATP5F1D
Interaction	PINK1 interactions	A2M NES CDSN LIMA1 MAP1B DSP COL5A3 RICTOR PPFIA3 OPA1 IQGAP1 MSH6 PARP1 CLINT1 NOP2 CLUH SON	1.70e-04	679	184	17	int:PINK1
Interaction	PCGF6 interactions	CRYBG2 CHAF1A RICTOR E2F4 ADNP USP21 ZNF644 TRIM63	1.80e-04	171	184	8	int:PCGF6
Interaction	ECT2 interactions	CCDC91 NES LIMA1 DSP FXR2 USP9X DAPK2 PPP1R9A TNIP1 TRRAP CDCA8 LYST IQGAP1 PARP1 SERINC3 NOP2 DNAH9 ZRANB1 DDX28 SON	1.83e-04	887	184	20	int:ECT2
Interaction	NEXN interactions	LIMA1 FXR2 PPP1R9A DAPK1 TNIP1 IQGAP1	1.87e-04	91	184	6	int:NEXN
Interaction	HDAC1 interactions	FN1 CHAF1A TRPS1 BACH1 TNIP1 E2F4 NR3C1 RUNX2 ADNP IQGAP1 TGIF1 DACT1 MSH6 PARP1 PTPN13 MRTFB OVOL1 NFATC1 CRYBG3 ZRANB1 OBI1 MRTFA DNMT3L	1.99e-04	1108	184	23	int:HDAC1
Interaction	RSPH1 interactions	ZBTB38 HIVEP2 FN1 USP9X PARP1 PTPRD SEZ6L	2.03e-04	131	184	7	int:RSPH1
Interaction	SFN interactions	SYNRG LIMA1 ABL2 MAP1B CARMIL1 BACH1 PARD3B RICTOR NR3C1 MAST2 NCKAP5L LYST PTPN13 AKAP13 CRYBG3 ZRANB1 OBI1	2.12e-04	692	184	17	int:SFN
Interaction	KSR1 interactions	LIMA1 RAB11FIP2 USP21 CCT8L2 PTPN13 TBC1D1 CRTC2	2.13e-04	132	184	7	int:KSR1
Interaction	SCAI interactions	ABL2 CHAF1A ADNP NFATC1 ZNF644	2.19e-04	60	184	5	int:SCAI
Interaction	FLYWCH1 interactions	TNIP1 PARP1 NFATC1 ZRANB1	2.24e-04	33	184	4	int:FLYWCH1
Interaction	ABLIM1 interactions	LIMA1 DAPK1 TNIP1 RICTOR IQGAP1 PARP1 PTPRD ZRANB1	2.27e-04	177	184	8	int:ABLIM1
Interaction	PHGDH interactions	EPN3 FN1 MAP1B TNIP1 RICTOR NR3C1 ADNP PARP1 NFATC1 ZRANB1 CLUH SON	2.28e-04	385	184	12	int:PHGDH
Interaction	ANKRD17 interactions	FXR2 CHAF1A RICTOR NR3C1 DDOST RNF214 MSH6 ZRANB1 OBI1	2.40e-04	226	184	9	int:ANKRD17
Interaction	SMAD3 interactions	USP9X BACH1 E2F4 NR3C1 RUNX2 OPA1 TGIF1 PARP1 PLAG1 ZRANB1 MRTFA DNMT3L PROX1	2.46e-04	447	184	13	int:SMAD3
Interaction	MYL1 interactions	FN1 TNIP1 IQGAP1 TRIM63 ZRANB1	2.55e-04	62	184	5	int:MYL1
GeneFamily	Ankyrin repeat domain containing\|Death associated protein kinases	DAPK2 DAPK1 DAPK3	3.27e-06	5	126	3	1021
GeneFamily	Beta-gamma crystallin domain containing	CRYBG2 CRYBG3	1.44e-04	3	126	2	1360
GeneFamily	Intermediate filaments Type IV	NES SYNM	7.10e-04	6	126	2	611
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	A2M CPAMD8	1.68e-03	9	126	2	1234
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TLK2 DMXL2 HIVEP2 MAP1B USP9X DLGAP5 DAPK1 NR3C1 ADNP LARS2 MAST2 TRRAP OPA1 TGIF1 NBAS MSH6 PTPN13 ARHGAP29 AKAP13 CLINT1 CRYBG3 MED13 MRTFA SON SEC14L1	2.24e-09	856	186	25	M4500
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	CCDC91 NPHS1 NES HIVEP2 BACH1 PARD3B CDC14A PTPN13 PTPRD TBC1D1	3.01e-06	212	186	10	M39221
Coexpression	CUI_TCF21_TARGETS_2_DN	NES ENDOD1 ZBTB38 HIVEP2 GOPC DSP USP9X ASH1L PARD3B RICTOR MINDY2 LYST CDC14A ARVCF TBC1D1 ARHGAP29 SERINC3 NOPCHAP1 MED13 SON	5.62e-06	888	186	20	MM1018
Coexpression	CUI_TCF21_TARGETS_2_DN	NES ENDOD1 ZBTB38 HIVEP2 GOPC DSP USP9X ASH1L PARD3B RICTOR MINDY2 LYST CDC14A ARVCF TBC1D1 ARHGAP29 SERINC3 MED13 SON	1.16e-05	854	186	19	M1533
Coexpression	GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	TRPM4 CRYBG2 FN1 IKZF4 TMEM273 OIT3 SERINC3 CLINT1 PIGO	1.33e-05	199	186	9	M8100
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPERIC	A2M LIMA1 MXRA5 ZBTB38 FN1 SYNM DSP RNF135 COL5A3 NR3C1 IQGAP1 ANKRD44 DACT1 ARAP3 ARHGAP29 PIP5K1B SERINC3 CCT8L1P	1.58e-05	795	186	18	M39050
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	RGPD4 ENDOD1 GOPC RAB11FIP2 RALGAPB RICTOR FAM98B ANKRD44 TGIF1 SUPV3L1 RGPD3 CLINT1 FGD3	3.68e-05	474	186	13	M40991
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	SYNRG ZBTB38 HIVEP2 USP9X TRPS1 RALGAPB ASH1L RICTOR NR3C1 RUNX2 LYST CDC14A IQGAP1 HIVEP3 ANKRD44 PARP1 SETD5 TBC1D1 ZNF644 PCNX1 AKAP13 OGA MED13 FGD3 SON	5.81e-05	1492	186	25	M40023
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	RAB11FIP2 OSER1 RICTOR RUNX2 CDC14A TASOR2 USP21 SUPV3L1 PCNX1 OGA ZRANB1 SON	6.52e-05	432	186	12	M41149
Coexpression	GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP	FN1 DAPK1 IKZF4 DACT1 OVOL1 CLINT1 RBM41 SEC14L1	8.02e-05	195	186	8	M8006
Coexpression	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP	ABL2 SYNM TRPS1 OSER1 MINDY2 VPS9D1 PTPN13 PCNX1	8.02e-05	195	186	8	M4195
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	RGPD4 USP9X ZNF385B RGPD3	8.55e-05	33	186	4	MM477
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN	EPN3 DMXL2 CRYBG2 CDSN CDC42EP4 FN1 SYNM CHAF1A BACH1 ASH1L TRGV5 MAST2 LYST MSH6 PTPRD TBC1D1 AKAP13 SEZ6L	8.95e-05	909	186	18	M41018
Coexpression	GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN	LIMA1 TRPS1 ASH1L LAMA3 LYST SUPV3L1 PIP5K1B OGA	9.24e-05	199	186	8	M3709
Coexpression	GSE28237_EARLY_VS_LATE_GC_BCELL_DN	MIA3 DSP ATP13A1 DAPK2 PARP3 MINDY2 MYO18B PIGO	9.57e-05	200	186	8	M4894
Coexpression	GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN	TLK2 ATP13A1 SARNP TASOR2 TGIF1 RNF214 PTPN13 ARVCF	9.57e-05	200	186	8	M3866
Coexpression	GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN	SYNRG RNF135 BACH1 TNIP1 PCDH20 VPS9D1 ZNF518B CRTC2	9.57e-05	200	186	8	M3877
Coexpression	GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN	ILRUN HIVEP2 RNF135 NR3C1 PCDH20 ANKRD44 RNF214 TBC1D1	9.57e-05	200	186	8	M7750
Coexpression	GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	ILRUN BPIFA4P RNF135 MAST2 CDC14A IQGAP1 NFATC1 SEC14L1	9.57e-05	200	186	8	M6514
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	SCFD2 RGPD4 GOPC NOC3L DAPK1 NR3C1 LARS2 OPA1 DDOST MSH6 PARP1 PTPRD TBC1D1 ZNF644 ARHGAP29 CLINT1 MYO18B CDON PROX1	1.09e-04	1009	186	19	M157
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TLK2 HIVEP2 MAP1B USP9X DAPK1 NR3C1 LARS2 TRRAP OPA1 ARHGAP29 MED13 SEC14L1	1.33e-04	466	186	12	M13522
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	A2M DMXL2 RAB11FIP2 ASH1L RUNX2 MAST2 ANKRD44 NBAS MSH6 POLQ	6.86e-09	186	187	10	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP9X ASH1L RICTOR CDC14A TASOR2 ANKRD44 ZNF644 PCNX1 MED13	1.07e-07	188	187	9	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	SYNRG MAP9 LCORL USP9X TASOR2 PCNX1 CRYBG3 MED13 SON	1.34e-07	193	187	9	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	NS-critical-d_07-13-Epithelial-Secretory\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GABRP LIMA1 CARMIL1 PCDH20 PTPN13 MRTFB ARHGAP29 NIPAL2 MSLN	1.40e-07	194	187	9	2172d951896265243d14996eacce5aab5e14e26e
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIA3 MAP1B COL6A6 USP9X ASH1L IQGAP1 SGCZ SEZ6L SON	1.46e-07	195	187	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIA3 MAP1B COL6A6 USP9X ASH1L IQGAP1 SGCZ SEZ6L SON	1.46e-07	195	187	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M NES MXRA5 FN1 MAP1B TNC RUNX2 PTPN13 PTPRD	1.67e-07	198	187	9	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	CPAMD8 DAPK2 PPP1R9A DAPK1 ZNF385B PTPN13 PTPRD CDON	1.01e-06	181	187	8	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	A2M FN1 TNC CARMIL1 LAMA3 TBC1D1 PIP5K1B PLD5	1.10e-06	183	187	8	818fd886e0188091310825f9145fa53328f2c979
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSP DAPK2 CARMIL1 LAMA3 DAPK1 ZNF385B PIP5K1B PLD5	1.20e-06	185	187	8	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-Tuft-related\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GABRP DSP CARMIL1 PPP1R9A ADGRG4 SH2D7 MSLN PROX1	1.20e-06	185	187	8	01d0e848d8ede2745cfb10b070e2d9674ef4d477
ToppCell	Tuft-tuft-2\|World / Class top	LIMA1 TNC PCDH20 NFATC1 PIP5K1B PNPLA3 SH2D7 PROX1	1.30e-06	187	187	8	4ec6eee866619dfe13c84f5d2e812bb380d37139
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMA1 LCORL DSP PPP1R9A ASH1L NR3C1 IQGAP1 CLINT1	1.52e-06	191	187	8	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMA1 LCORL DSP PPP1R9A ASH1L NR3C1 IQGAP1 CLINT1	1.52e-06	191	187	8	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMA1 LCORL DSP PPP1R9A ASH1L NR3C1 IQGAP1 CLINT1	1.52e-06	191	187	8	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DAPK2 CARMIL1 PPP1R9A LAMA3 ZNF385B PTPN13 PTPRD PIP5K1B	1.71e-06	194	187	8	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	Control-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	DAPK2 TRPS1 NR3C1 RUNX2 CDC14A PTPN13 PCNX1 AKAP13	1.77e-06	195	187	8	6687e579582d7a239bee80846de0cf827a6f6a62
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HIVEP2 MAP1B STXBP5L CARMIL1 ZNF385B NR3C1 MRTFB PTPRD	1.77e-06	195	187	8	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	DAPK2 PPP1R9A PARD3B ZNF385B HIVEP3 ANKRD44 PTPRD PIP5K1B	1.84e-06	196	187	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	critical-Epithelial-Secretory\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GABRP LIMA1 CARMIL1 PCDH20 PTPN13 MRTFB NIPAL2 MSLN	1.84e-06	196	187	8	7da687eb983a54c28ee990424cc52e01caf5f4aa
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	A2M NES LIMA1 MRTFB ARHGAP29 SERINC3 CRYBG3 SEC14L1	1.91e-06	197	187	8	66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M NES MXRA5 FN1 MAP1B TNC RUNX2 PTPRD	1.99e-06	198	187	8	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	Sepsis-ICU-NoSEP-Myeloid-tDC\|ICU-NoSEP / Disease, condition lineage and cell class	TRPM4 LIMA1 ZNF618 DAPK2 CHAF1A ANGEL1 RUNX2 NOP2	2.06e-06	199	187	8	90ddd686b8f39c6f6134b9b048396cebcf8d0448
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M NES MXRA5 FN1 MAP1B TNC RUNX2 PTPRD	2.06e-06	199	187	8	7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPN3 CACNA1F DSP DAPK2 LAMA3 DAPK1 PLD5 FGD3	2.06e-06	199	187	8	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPN3 GABRP LIMA1 MXRA5 DSP PTPN13 NIPAL2 CLINT1	2.06e-06	199	187	8	fbd39d34636137d1b877dd8815d58f124990136b
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GABRP LIMA1 CARMIL1 PCDH20 PTPN13 MRTFB NIPAL2 MSLN	2.06e-06	199	187	8	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M NES MXRA5 FN1 MAP1B TNC RUNX2 PTPRD	2.06e-06	199	187	8	f2ad641f36c577ff7019e88ad6b73ed7e46d8c74
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPN3 GABRP LIMA1 MXRA5 DSP PTPN13 NIPAL2 CLINT1	2.06e-06	199	187	8	6977f939ddbc47d4921f36c0a61a205259fe1284
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GABRP LIMA1 MIA3 CARMIL1 PTPN13 MRTFB NIPAL2 MSLN	2.06e-06	199	187	8	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GABRP LIMA1 CARMIL1 PTPN13 MRTFB NIPAL2 CLINT1 MSLN	2.06e-06	199	187	8	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PPP1R9A ASH1L MRTFB ARAP3 ARHGAP29 ZNF518B SON SEC14L1	2.14e-06	200	187	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	DMXL2 DAPK2 CHAF1A RAB11FIP2 DLGAP5 DCLRE1B SERINC3 POLQ	2.14e-06	200	187	8	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M MXRA5 FN1 MAP1B TNC COL5A3 RUNX2 PTPN13	2.14e-06	200	187	8	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial\|10w / Sample Type, Dataset, Time_group, and Cell type.	A2M FN1 RNF135 COL5A3 RUNX2 ARHGAP29 TRIM63 MSLN	2.14e-06	200	187	8	ff0b2675c68e9fc1fa16b3276431f199f3642eac
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell\|10w / Sample Type, Dataset, Time_group, and Cell type.	A2M FN1 RNF135 COL5A3 RUNX2 ARHGAP29 TRIM63 MSLN	2.14e-06	200	187	8	07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	CPAMD8 DAPK2 DAPK1 ZNF385B PTPN13 PIP5K1B AKAP13	5.90e-06	163	187	7	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	LPS_only-Epithelial_airway-Club_cells-Airway\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GABRP CRYBG2 DSP SGCZ OVOL1 PLD5 MSLN	6.15e-06	164	187	7	b1243b10591e1e15a94952e39ffbf382eae6aae8
ToppCell	LPS_only-Epithelial_airway-Club_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GABRP CRYBG2 DSP SGCZ OVOL1 PLD5 MSLN	6.15e-06	164	187	7	c5b2001280a43da855017361a3f6071a0e492848
ToppCell	LPS_only-Epithelial_airway\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GABRP CRYBG2 DSP SGCZ OVOL1 PLD5 MSLN	6.15e-06	164	187	7	56e6934e6c7503a300d7be06762d45a1d6f1ae0f
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	A2M FN1 TNC CARMIL1 LAMA3 MRTFB TBC1D1	8.08e-06	171	187	7	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DMXL2 HIVEP2 NFATC1 GPR153 PNPLA3 SH2D7 PROX1	9.39e-06	175	187	7	f24b664b9056b5976bf2222e8013f15c09e049ad
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZBTB38 PPP1R9A FCN3 CDC14A MRTFB ARAP3 ARHGAP29	1.01e-05	177	187	7	b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC91 NPHS1 NES MAP1B PARD3B CDC14A PTPRD	1.01e-05	177	187	7	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSP DAPK2 CARMIL1 LAMA3 DAPK1 PLD5 FGD3	1.01e-05	177	187	7	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSP DAPK2 CARMIL1 LAMA3 DAPK1 PLD5 FGD3	1.05e-05	178	187	7	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC91 NPHS1 NES MAP1B PARD3B CDC14A PTPRD	1.05e-05	178	187	7	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DAPK2 PPP1R9A LAMA3 DAPK1 PARD3B ZNF385B PIP5K1B	1.09e-05	179	187	7	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	ICU-NoSEP-Myeloid-tDC\|ICU-NoSEP / Disease, Lineage and Cell Type	TRPM4 LIMA1 ZNF618 DAPK2 CHAF1A RUNX2 MSLN	1.13e-05	180	187	7	be665e801512f6aaf6b3ecb26153bbdeb24619ac
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC91 NPHS1 PARD3B CDC14A PTPN13 PTPRD DNAH9	1.26e-05	183	187	7	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC91 NPHS1 PARD3B CDC14A PTPN13 PTPRD DNAH9	1.26e-05	183	187	7	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SCFD2 COL6A6 TNC CHAF1A TRPS1 NCKAP5L SEZ6L	1.26e-05	183	187	7	1464b5c4425e8776c4aeb4d2b560481d4bf13931
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	A2M FN1 TNC CARMIL1 LAMA3 TBC1D1 PLD5	1.26e-05	183	187	7	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSP DAPK2 LAMA3 DAPK1 ZNF385B PTPN13 PIP5K1B	1.30e-05	184	187	7	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK2 LAMA3 DAPK1 ZNF385B PTPN13 PIP5K1B CDON	1.35e-05	185	187	7	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	A2M DMXL2 RAB11FIP2 MAST2 ANKRD44 NBAS POLQ	1.35e-05	185	187	7	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	PND01-03-samps-Epithelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DSP DAPK2 PPP1R9A LAMA3 ZNF385B PIP5K1B MSLN	1.35e-05	185	187	7	2b854df79cfe2cb4d2f9c2938a066e0aa3649325
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 TRPS1 NR3C1 LYST IQGAP1 PARP1 CLINT1	1.35e-05	185	187	7	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B DSP USP9X BACH1 ASH1L TGIF1 NFATC1	1.35e-05	185	187	7	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FN1 TNC TRPS1 NR3C1 DACT1 PTPRD GPR153	1.35e-05	185	187	7	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	Tuft\|World / Class top	LIMA1 TNC PCDH20 NFATC1 PIP5K1B PNPLA3 SH2D7	1.40e-05	186	187	7	f4d83f15ab7b49c0920a322cd832413ece7c9948
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSP DAPK2 LAMA3 DAPK1 ZNF385B PTPN13 PLD5	1.44e-05	187	187	7	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	PND01-03-samps-Epithelial-Alveolar_epithelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DSP DAPK2 PPP1R9A LAMA3 ZNF385B PIP5K1B MSLN	1.44e-05	187	187	7	23fe3cdd6cc9b067086a8392d104186d300298ea
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CPAMD8 DAPK2 PPP1R9A LAMA3 DAPK1 ZNF385B PTPN13	1.60e-05	190	187	7	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	A2M RUNX2 LYST IQGAP1 ANKRD44 NBAS POLQ	1.66e-05	191	187	7	9454f642c3621370fa23640b631301346b300950
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	CPAMD8 DAPK2 PPP1R9A LAMA3 DAPK1 ZNF385B PTPN13	1.66e-05	191	187	7	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRP TRPM4 DSP PPP1R9A MUC16 CLINT1 MSLN	1.71e-05	192	187	7	c227ab1914191e839fc39c9adc2080026d4b04fc
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRP TRPM4 DSP PPP1R9A MUC16 CLINT1 MSLN	1.71e-05	192	187	7	bf187a57a559ab732bb815892af45ca922966ac6
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRP TRPM4 DSP PPP1R9A MUC16 CLINT1 MSLN	1.71e-05	192	187	7	f573b2d205bd4d053a548af3fe3ff9de7be0cd2b
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DAPK2 PPP1R9A LAMA3 DAPK1 ZNF385B PIP5K1B AKAP13	1.71e-05	192	187	7	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	DAPK2 PPP1R9A LAMA3 PARD3B ZNF385B PTPN13 PIP5K1B	1.71e-05	192	187	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENDOD1 USP9X LAMA3 LARS2 CDC14A PARP1 SERINC3	1.71e-05	192	187	7	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GABRP CPAMD8 PPP1R9A LAMA3 DAPK1 ARHGAP29 DNAI4	1.77e-05	193	187	7	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP1R9A ANGEL1 FCN3 MRTFB ARAP3 PTPRD SEC14L1	1.77e-05	193	187	7	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	DSP PPP1R9A PARD3B PIP5K1B PLAG1 MED13 PROX1	1.77e-05	193	187	7	503a979328c68b096680b71359a26f02fafdff35
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	DSP PPP1R9A PARD3B RICTOR SETD5 PLAG1 MED13	1.77e-05	193	187	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CPAMD8 DAPK2 PPP1R9A LAMA3 DAPK1 ZNF385B PTPN13	1.77e-05	193	187	7	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GABRP CPAMD8 PPP1R9A LAMA3 DAPK1 ARHGAP29 DNAI4	1.77e-05	193	187	7	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	COVID-19-kidney-Mito-rich_Int\|kidney / Disease (COVID-19 only), tissue and cell type	KCNH7 STXBP5L SGCZ PLD5 MYO18B DNAH9	1.77e-05	129	187	6	57b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCell	PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DSP DLGAP5 LAMA3 CDCA8 VWDE POLQ BORA	1.83e-05	194	187	7	c197e4acbff42a9f0410b6801c2bfcf6160aefc1
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DAPK2 PPP1R9A LAMA3 PARD3B ZNF385B PTPN13 PIP5K1B	1.83e-05	194	187	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPHS1 KCNH7 DSP PARP3 MUC16 PPFIA3 PROX1	1.83e-05	194	187	7	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DAPK2 PPP1R9A LAMA3 PARD3B ZNF385B PTPN13 PIP5K1B	1.89e-05	195	187	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M COL5A3 TMEM273 MRTFB TBC1D1 ARHGAP29 PIP5K1B	1.96e-05	196	187	7	c16fbd23d9e117831b55ab3da5b08b22dd972432
ToppCell	healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	A2M SYNRG HIVEP2 SYNM COL5A3 RUNX2 CDC14A	1.96e-05	196	187	7	6eabbac1625f715531bae562a28da27664572600
ToppCell	critical-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GABRP LIMA1 CARMIL1 PCDH20 MRTFB NIPAL2 MSLN	1.96e-05	196	187	7	dbf14f5851c2b779a8b35e820c4584ea9096e49d
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M MXRA5 FN1 TNC COL5A3 RUNX2 PTPN13	2.02e-05	197	187	7	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	A2M NES MXRA5 FN1 MAP1B TNC RUNX2	2.02e-05	197	187	7	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CACNA1F DSP DAPK2 LAMA3 DAPK1 PTPN13 SON	2.02e-05	197	187	7	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	A2M FN1 COL6A6 TNC TRPS1 HIVEP3 PTPRD	2.02e-05	197	187	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M NES FN1 MAP1B FCN3 ARAP3 CRYBG3	2.09e-05	198	187	7	5e781583908c4ee107d986904a646a7c6b8e3591
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M NES FN1 MAP1B TNC RUNX2 PTPRD	2.09e-05	198	187	7	6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPAMD8 DSP DAPK2 DAPK1 RUNX2 PTPN13 PTPRD	2.09e-05	198	187	7	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	NS-critical-LOC-Epithelial-Secretory_LYPD2\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GABRP LIMA1 DSP MUC16 PTPN13 CLINT1 MSLN	2.09e-05	198	187	7	4a481e1edb80b950c823ed926842cd5132cfb27f
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M NES CPAMD8 ABL2 FN1 ARAP3 ARHGAP29	2.09e-05	198	187	7	58508a8df2714d769f137794c29441a7bd38b350
ToppCell	COVID-19_Severe-cDC\|COVID-19_Severe / Disease condition and Cell class	LIMA1 DDOST TMEM273 PARP1 NOPCHAP1 SEZ6L MSLN	2.09e-05	198	187	7	e0b16627a347e245bedd71b1e0ccdb46c1c1bd6d
ToppCell	Caecum-T_cell-Treg\|T_cell / Region, Cell class and subclass	LIMA1 ZBTB38 TRPS1 BACH1 NR3C1 PARP1 NIPAL2	2.09e-05	198	187	7	90a2a75ca078f7088b8739795a9b396113bcbe23
ToppCell	COVID-19_Severe-cDC-\|COVID-19_Severe / Disease condition and Cell class	LIMA1 DDOST TMEM273 PARP1 NOPCHAP1 SEZ6L MSLN	2.09e-05	198	187	7	3914140238598914674c08c5ad83354b9485825f
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DAPK2 PPP1R9A LAMA3 DAPK1 ZNF385B PTPN13 PIP5K1B	2.16e-05	199	187	7	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	A2M TLK2 ASH1L RICTOR CDC14A ANKRD44 ZNF644	2.16e-05	199	187	7	f0b0097df0026496470a80d8cc9375ffd8389b00
Drug	Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; PC3; HT_HG-U133A	CRYBG2 HIVEP2 FN1 MAP1B MLLT10 IL23A TIGD6 PITPNM1 DNAI4 OGA CDON	7.41e-07	198	186	11	5738_DN
Drug	Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A	A2M HIVEP2 DAPK2 RAB11FIP2 LAMA3 NR3C1 RUNX2 PQBP1 PITPNM1 NFATC1 MRTFA	7.41e-07	198	186	11	5414_UP
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A	ILRUN ZBTB38 MAP1B PPP1R9A LYST IQGAP1 PCNX1 AKAP13 ZC3H7B SEC14L1	3.88e-06	190	186	10	4307_DN
Drug	Chlorthalidone [77-36-1]; Down 200; 11.8uM; HL60; HG-U133A	SYNRG MIA3 ANGEL1 NR3C1 MINDY2 ARAP3 PCNX1 ZC3H7B OGA RBM41	4.67e-06	194	186	10	1581_DN
Drug	Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A	HIVEP2 MAP1B DAPK3 MAST2 MINDY2 LYST ARVCF AKAP13 ZC3H7B OGA	5.35e-06	197	186	10	1508_DN
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	PPFIA3 IL23A CDC14A VPS9D1 ARVCF PCNX1 AKAP13 ZC3H7B OGA MRTFA	5.59e-06	198	186	10	6043_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A	LIMA1 FN1 CHAF1A E2F4 MAST2 TRRAP SERINC3 OGA MED13 DDX28	5.59e-06	198	186	10	2002_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SYNRG MIA3 DAPK3 NR3C1 MAST2 CDC14A VPS9D1 ARVCF DNAI4 PCNX1	5.59e-06	198	186	10	6053_DN
Drug	Nitrofurantoin [67-20-9]; Up 200; 16.8uM; HL60; HT_HG-U133A	CDC42EP4 FN1 DAPK2 E2F4 MAST2 PQBP1 IKZF4 HIVEP3 NFATC1 DNAI4	5.85e-06	199	186	10	2341_UP
Drug	Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A	A2M FN1 STXBP5L DAPK1 PPFIA3 MAST2 ARVCF ZC3H7B MSLN CDON	5.85e-06	199	186	10	2765_UP
Drug	CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A	CRYBG2 ABL2 DAPK3 PQBP1 HIVEP3 OVOL1 ARVCF UCP1 NIPAL2 SEZ6L	6.11e-06	200	186	10	3822_DN
Drug	Magnetite Nanoparticles	ENDOD1 MIA3 FN1 USP9X PARP3 TRPS1 ASH1L TNIP1 MLLT10 NR3C1 RUNX2 PPFIA3 NCKAP5L MINDY2 PITPNM1 HIVEP3 ANKRD44 NEK3 OIT3 ARAP3 ZNF644 PIP5K1B SERINC3 ZRANB1 MED13 FGD3 DNMT3L	8.70e-06	1310	186	27	ctd:D058185
Drug	Succimer	ENDOD1 MIA3 FN1 USP9X PARP3 TRPS1 ASH1L TNIP1 MLLT10 NR3C1 RUNX2 PPFIA3 MINDY2 PITPNM1 HIVEP3 ANKRD44 NEK3 OIT3 ARAP3 ZNF644 PIP5K1B SERINC3 ZRANB1 MED13 FGD3 DNMT3L	1.35e-05	1264	186	26	ctd:D004113
Drug	GW8510; Down 200; 10uM; MCF7; HT_HG-U133A	SYNRG CDC42EP4 DCLRE1B MLLT10 ADNP TGIF1 MSH6 MRTFB DDX28	2.05e-05	183	186	9	7062_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	HIVEP2 PPP1R9A DAPK3 NR3C1 MAST2 VPS9D1 OVOL1 PCNX1 ZC3H7B	2.87e-05	191	186	9	6024_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	ILRUN MAP1B ASH1L LYST IQGAP1 PCNX1 AKAP13 OGA SEC14L1	2.87e-05	191	186	9	4283_DN
Drug	AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A	CCDC91 CRYBG2 ZBTB38 FXR2 RAB11FIP2 NR3C1 IQGAP1 AKAP13 SEC14L1	3.12e-05	193	186	9	6920_UP
Drug	o-nitrophenyl beta-D-fucopyranoside	EPN3 SYNRG RAB11FIP2 OPA1 SNAP91 CLINT1	3.20e-05	74	186	6	CID000004597
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	TNC STXBP5L DAPK3 E2F4 PPFIA3 CDC14A PITPNM1 STS OGA	3.25e-05	194	186	9	3422_UP
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	RAB11FIP2 ASH1L MINDY2 STS NIPAL2 PCNX1 ZC3H7B MRTFA CDON	3.25e-05	194	186	9	6021_DN
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; MCF7; HT_HG-U133A	A2M CHAF1A LAMA3 E2F4 PPFIA3 PQBP1 MINDY2 STS ARVCF	3.25e-05	194	186	9	5454_DN
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; MCF7; HT_HG-U133A	ABL2 DAPK2 PARP3 NR3C1 MINDY2 PITPNM1 VPS9D1 ARVCF PCNX1	3.25e-05	194	186	9	7347_UP
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	ILRUN ENDOD1 ZBTB38 MAP1B IQGAP1 PCNX1 AKAP13 ZC3H7B SEC14L1	3.25e-05	194	186	9	4312_DN
Drug	5140203; Down 200; 15uM; MCF7; HT_HG-U133A_EA	ENDOD1 FXR2 CHAF1A ZNF180 E2F4 MAST2 TIGD6 GPR153 ZC3H7B	3.38e-05	195	186	9	908_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A	ABL2 E2F4 NR3C1 LYST TIGD6 NIPAL2 AKAP13 ZC3H7B MRTFA	3.52e-05	196	186	9	3199_DN
Drug	Thalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ILRUN ABL2 E2F4 DDOST IQGAP1 ARVCF NIPAL2 AKAP13 SEC14L1	3.52e-05	196	186	9	2258_DN
Drug	Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; PC3; HT_HG-U133A	CRYBG2 MAP1B TRPS1 E2F4 MINDY2 CDC14A STS PCNX1 PIGO	3.52e-05	196	186	9	4685_UP
Drug	Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; MCF7; HT_HG-U133A	ABL2 NR3C1 PPFIA3 MAST2 PITPNM1 HIVEP3 PCNX1 ZC3H7B OGA	3.52e-05	196	186	9	3541_DN
Drug	Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; HL60; HT_HG-U133A	CDC42EP4 MAP1B ASH1L DAPK1 MLLT10 PQBP1 PCNX1 ZC3H7B MRTFA	3.52e-05	196	186	9	2355_UP
Drug	Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	MAP1B STXBP5L ASH1L MINDY2 STS NIPAL2 ZC3H7B MRTFA CDON	3.66e-05	197	186	9	3551_UP
Drug	Dacarbazine [4342-03-4]; Up 200; 22uM; PC3; HT_HG-U133A	ZBTB38 MAST2 PQBP1 OVOL1 STS ARVCF OGA MRTFA PROX1	3.66e-05	197	186	9	4480_UP
Drug	Droperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CRYBG2 FXR2 PARP3 TIGD6 STS NIPAL2 DDX28 MRTFA SEZ6L	3.66e-05	197	186	9	2645_UP
Drug	Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; HL60; HT_HG-U133A	FN1 TNC DAPK1 TIGD6 GPR153 NIPAL2 ZC3H7B CDON SEC14L1	3.81e-05	198	186	9	2902_UP
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A	MAP9 FXR2 PPFIA3 MAST2 PQBP1 LYST HIVEP3 PIGO MRTFA	3.81e-05	198	186	9	3196_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MIA3 ABL2 CHAF1A PARP3 DAPK3 NR3C1 MAST2 HIVEP3 OGA	3.81e-05	198	186	9	4351_DN
Drug	Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; MCF7; HT_HG-U133A	CHAF1A E2F4 PPFIA3 LYST TIGD6 NEK3 PCNX1 PIGO CDON	3.96e-05	199	186	9	6496_DN
Drug	Niflumic acid [4394-00-7]; Up 200; 14.2uM; PC3; HT_HG-U133A	GABRP FN1 MINDY2 HIVEP3 ARVCF NIPAL2 PLAG1 PIGO SEZ6L	3.96e-05	199	186	9	5071_UP
Drug	ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A_EA	MIA3 HIVEP2 SYNM PPFIA3 PQBP1 TIGD6 PITPNM1 NIPAL2 ZC3H7B	3.96e-05	199	186	9	985_UP
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; HL60; HG-U133A	ILRUN ENDOD1 MIA3 FN1 GPR153 SERINC3 PCNX1 ZC3H7B SON	3.96e-05	199	186	9	1588_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	ENDOD1 MAP9 SYNM CHAF1A ASH1L LARS2 LYST MSH6 NEK3	4.12e-05	200	186	9	6996_DN
Drug	NSC-364372	EPN3 NES FXR2 DLGAP5 NR3C1 RUNX2 TRRAP CDCA8 CDC14A IQGAP1 DACT1 NFATC1 CLINT1 MSLN	4.71e-05	484	186	14	CID000435143
Drug	7-tricosene	TRRAP LYST	6.64e-05	2	186	2	CID006365493
Drug	2,4,5,2',5'-pentachlorobiphenyl	ILRUN GABRP CACNA1F FN1 MAP1B STXBP5L CHAF1A DLGAP5 DAPK1 NR3C1 RUNX2 PPFIA3 CDCA8 IL23A PITPNM1 DACT1 MSH6 PARP1 ARVCF CRYBG3 POLQ OBI1 RBM41 CDON DNMT3L BORA	1.20e-04	1441	186	26	ctd:C009828
Drug	Ellipticine [519-23-3]; Up 200; 16.2uM; MCF7; HT_HG-U133A	A2M HIVEP2 NR3C1 LYST CDC14A STS ARVCF ZC3H7B	1.40e-04	184	186	8	2758_UP
Drug	Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A	ENDOD1 E2F4 PPFIA3 CDCA8 MSH6 POLQ PIGO DDX28	1.51e-04	186	186	8	3518_DN
Drug	5182598; Up 200; 25uM; MCF7; HT_HG-U133A_EA	MAP1B SYNM RAB11FIP2 BACH1 E2F4 PITPNM1 ARVCF OGA	1.57e-04	187	186	8	868_UP
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A	ILRUN DMXL2 ANGEL1 LYST CDC14A PCNX1 ZC3H7B OGA	1.63e-04	188	186	8	1865_DN
Drug	geldanamycin; Up 200; 1uM; MCF7; HG-U133A	CRYBG2 FXR2 NR3C1 PITPNM1 HIVEP3 NBAS PTPRD ARVCF	1.69e-04	189	186	8	611_UP
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	MIA3 FXR2 CHAF1A PPP1R9A DAPK3 MAST2 DDX28 SEC14L1	1.75e-04	190	186	8	4362_DN
Drug	Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A	MAP1B FXR2 LAMA3 GPR153 PCNX1 AKAP13 ZC3H7B SEC14L1	1.81e-04	191	186	8	7435_DN
Drug	progesterone acetate	FN1 TNC SERINC3	1.83e-04	14	186	3	CID000134580
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; HL60; HT_HG-U133A	ENDOD1 FN1 MAP1B DAPK3 E2F4 MLLT10 HIVEP3 PCNX1	1.95e-04	193	186	8	2346_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CDC42EP4 FXR2 PARP3 LARS2 STS CLUH OBI1 PIGO	1.95e-04	193	186	8	3262_UP
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	ILRUN SYNM FXR2 RAB11FIP2 MAST2 TRRAP GPR153 SEC14L1	1.95e-04	193	186	8	6967_DN
Drug	Carcinine [56897-53-1]; Down 200; 22uM; MCF7; HT_HG-U133A	TRPM4 SYNRG MAST2 CDC14A NIPAL2 AKAP13 ZC3H7B OGA	1.95e-04	193	186	8	3242_DN
Drug	Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A	DMXL2 CRYBG2 ABL2 FN1 CDC14A STS ZC3H7B OGA	1.95e-04	193	186	8	3344_UP
Drug	1,2-naphthoquinone-4-sulfonate	A2M PQBP1	1.98e-04	3	186	2	CID000010637
Drug	RU 52461	NR3C1 IKZF4	1.98e-04	3	186	2	CID000132349
Drug	4-vinylaniline	FN1 TNIP1	1.98e-04	3	186	2	CID000073700
Drug	Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; MCF7; HT_HG-U133A	MAP9 ABL2 CDC14A PITPNM1 HIVEP3 VPS9D1 PCNX1 OGA	2.02e-04	194	186	8	3903_DN
Drug	Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A	FN1 MAP1B DAPK2 NR3C1 MAST2 NIPAL2 ZC3H7B MRTFA	2.02e-04	194	186	8	7164_UP
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	ILRUN CHAF1A LAMA3 E2F4 PPFIA3 GRSF1 MSH6 ZC3H7B	2.02e-04	194	186	8	6995_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	ZBTB38 FXR2 DAPK3 IQGAP1 SERINC3 AKAP13 SON SEC14L1	2.02e-04	194	186	8	4361_DN
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A	ILRUN FN1 DLGAP5 MAST2 PCNX1 AKAP13 ZC3H7B OGA	2.02e-04	194	186	8	2009_DN
Drug	trimethoprim-sulfamethoxazole	FXR2 TNIP1 PQBP1 LYST MRTFA	2.06e-04	66	186	5	CID000358641
Drug	5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA	SYNM E2F4 NR3C1 PPFIA3 MAST2 PITPNM1 NEK3 GPR153	2.09e-04	195	186	8	834_UP
Drug	Atovaquone [95233-18-4]; Up 200; 11uM; HL60; HT_HG-U133A	A2M DMXL2 CRYBG2 ZBTB38 ABL2 STS ZC3H7B MRTFA	2.09e-04	195	186	8	2480_UP
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A	CHAF1A DAPK3 E2F4 MAST2 CDC14A IQGAP1 OVOL1 SEC14L1	2.09e-04	195	186	8	3835_DN
Drug	Tamoxifen citrate [54965-24-1]; Down 200; 7uM; HL60; HG-U133A	ILRUN SYNRG FN1 RAB11FIP2 ASH1L IL23A ZC3H7B OGA	2.09e-04	195	186	8	1366_DN
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A	ZBTB38 RAB11FIP2 NOC3L E2F4 MLLT10 MSH6 PTPN13 TBC1D1	2.09e-04	195	186	8	6959_DN
Drug	Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A	ILRUN MLLT10 NR3C1 MAST2 GPR153 NIPAL2 CLUH MRTFA	2.09e-04	195	186	8	1687_DN
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	ZBTB38 FXR2 PPP1R9A RAB11FIP2 NR3C1 DDOST IQGAP1 SEC14L1	2.09e-04	195	186	8	6918_UP
Drug	Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; MCF7; HT_HG-U133A	MLLT10 CDC14A NEK3 NFATC1 NIPAL2 DNAI4 OGA PROX1	2.09e-04	195	186	8	7237_UP
Drug	Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A	PARP3 E2F4 PITPNM1 STS NIPAL2 AKAP13 OGA CDON	2.09e-04	195	186	8	5093_DN
Drug	Solanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A	CRYBG2 MAP1B TNC CDC14A VPS9D1 GPR153 NIPAL2 ZC3H7B	2.09e-04	195	186	8	2152_UP
Drug	Sulfaquinoxaline sodium salt [967-80-6]; Up 200; 12.4uM; HL60; HT_HG-U133A	MXRA5 TNC DAPK3 RUNX2 CDC14A MRTFB STS MRTFA	2.16e-04	196	186	8	2528_UP
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; PC3; HT_HG-U133A	CRYBG2 MLLT10 PQBP1 TIGD6 NEK3 DNAI4 OGA MRTFA	2.16e-04	196	186	8	5749_DN
Drug	Aminocaproic acid [60-32-2]; Up 200; 30.4uM; HL60; HT_HG-U133A	NES ENDOD1 FN1 RUNX2 FCN3 LARS2 MAST2 NFATC1	2.16e-04	196	186	8	3122_UP
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; HL60; HG-U133A	ANGEL1 MAST2 TRRAP ARVCF NIPAL2 PCNX1 MRTFA SEZ6L	2.16e-04	196	186	8	1738_UP
Drug	PF-00539758-00 [351321-34-1]; Up 200; 10uM; MCF7; HT_HG-U133A	CRYBG2 TNC NR3C1 VPS9D1 ARVCF DNAI4 PCNX1 DDX28	2.16e-04	196	186	8	6416_UP
Drug	Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SYNRG DAPK3 PPFIA3 VPS9D1 ARVCF PCNX1 RBM41 SEC14L1	2.16e-04	196	186	8	3350_DN
Drug	Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A	A2M FN1 PARP3 DAPK3 IKZF4 ARVCF MRTFA SEZ6L	2.16e-04	196	186	8	4773_UP
Drug	Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; HL60; HT_HG-U133A	HIVEP2 CDC42EP4 BACH1 MAST2 PITPNM1 PIGO MRTFA SEC14L1	2.16e-04	196	186	8	2493_DN
Drug	2,4,4'-trichlorobiphenyl	ILRUN GABRP CACNA1F FN1 MAP1B STXBP5L CHAF1A DLGAP5 DAPK1 NR3C1 RUNX2 PPFIA3 CDCA8 IL23A PITPNM1 DACT1 MSH6 ARVCF CRYBG3 POLQ OBI1 RBM41 CDON DNMT3L BORA	2.17e-04	1411	186	25	ctd:C081766
Drug	SC 19220; Down 200; 10uM; MCF7; HT_HG-U133A	DMXL2 DSP NR3C1 PPFIA3 MINDY2 DDOST NEK3 SEC14L1	2.24e-04	197	186	8	7060_DN
Drug	Cinnarizine [298-57-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	DAPK2 BACH1 E2F4 NR3C1 TIGD6 NIPAL2 ZC3H7B CDON	2.24e-04	197	186	8	7174_UP
Drug	Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A	CRYBG2 ABL2 PPP1R9A DAPK3 E2F4 OVOL1 GPR153 ZC3H7B	2.24e-04	197	186	8	6803_UP
Drug	aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A	CCDC91 CRYBG2 ABL2 DAPK2 PARP3 TRPS1 DAPK3 PPFIA3	2.24e-04	197	186	8	2664_UP
Drug	Debrisoquin sulfate [581-88-4]; Down 200; 9uM; MCF7; HT_HG-U133A	DAPK2 NR3C1 PPFIA3 MINDY2 STS ARVCF ZC3H7B CDON	2.24e-04	197	186	8	3207_DN
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	A2M DMXL2 TNC IL23A CDC14A ARVCF ZC3H7B CDON	2.24e-04	197	186	8	3399_DN
Drug	Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A	NR3C1 PPFIA3 PQBP1 CDC14A HIVEP3 ARVCF AKAP13 MRTFA	2.24e-04	197	186	8	3195_DN
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A	HIVEP2 DCLRE1B NR3C1 PPFIA3 CDC14A PTPN13 AKAP13 PIGO	2.24e-04	197	186	8	1810_DN
Drug	Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; PC3; HT_HG-U133A	DMXL2 FN1 MLLT10 HIVEP3 STS ARVCF PIP5K1B PROX1	2.24e-04	197	186	8	5761_UP
Drug	Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAP9 CDC42EP4 SYNM MLLT10 NEK3 STS NIPAL2 RBM41	2.32e-04	198	186	8	4837_DN
Drug	Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A	MAP9 MIA3 ZBTB38 HIVEP2 GRSF1 STS ARVCF GPR153	2.32e-04	198	186	8	3419_UP
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A	MIA3 ASH1L DAPK3 PPFIA3 OVOL1 ARVCF MRTFA SEZ6L	2.32e-04	198	186	8	5904_DN
Drug	Reserpine [50-55-5]; Down 200; 6.6uM; HL60; HT_HG-U133A	GABRP DAPK3 MLLT10 MINDY2 PITPNM1 ARAP3 STS MRTFA	2.32e-04	198	186	8	3003_DN
Drug	fluphenazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	CRYBG2 RALGAPB MLLT10 MINDY2 MRTFB STS NIPAL2 PCNX1	2.32e-04	198	186	8	1178_UP
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	NR3C1 PPFIA3 VPS9D1 ARVCF PCNX1 ZC3H7B PIGO RBM41	2.32e-04	198	186	8	1491_DN
Drug	Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A	LAMA3 LARS2 LYST CDC14A NBAS CDON BORA SEC14L1	2.32e-04	198	186	8	5361_UP
Disease	coronary artery disease	ILRUN MIA3 KCNH7 HIVEP2 FN1 MAP1B LCORL CARMIL1 PPP1R9A DCLRE1B RUNX2 VWDE SGCZ PARP1 OIT3 ARVCF AKAP13 PNPLA3 MRTFA SEZ6L	4.11e-05	1194	179	20	EFO_0001645
Disease	lymphocyte count	ILRUN SYNRG LIMA1 ZBTB38 FN1 LCORL PCDHGA2 NOC3L OSER1 TNIP1 LYST IQGAP1 NFATC1 ARVCF PCDHGA12 TBC1D1 SUPV3L1 ZNF644 PLAG1 ZC3H7B OBI1 MRTFA	8.34e-05	1464	179	22	EFO_0004587
Disease	Colorectal Carcinoma	CPAMD8 FN1 MAP1B PQBP1 CDC14A HIVEP3 DACT1 MSH6 PARP1 ARAP3 PTPRD NFATC1 SNX8 PIGO	1.05e-04	702	179	14	C0009402
Disease	Neurodevelopmental Disorders	ASH1L PARD3B ADNP HIVEP3 SETD5	2.62e-04	93	179	5	C1535926
Disease	cognitive function measurement, self reported educational attainment	DMXL2 KCNH7 LCORL CARMIL1 IKZF4 SGCZ ZC3H7B OGA MRTFA	3.38e-04	355	179	9	EFO_0004784, EFO_0008354
Disease	Attention deficit hyperactivity disorder	STS PTPRD MED13	4.05e-04	24	179	3	C1263846
Disease	breast carcinoma	SCFD2 CCDC91 ZBTB38 TRPS1 ASH1L DCLRE1B MLLT10 NR3C1 MAST2 CDC14A TASOR2 HIVEP3 OVOL1 PTPRD ZC3H7B MRTFA	5.07e-04	1019	179	16	EFO_0000305
Disease	lean body mass	ZBTB38 HIVEP2 LCORL TRPS1 PARD3B PTPRD TRIM63 PLAG1 AKAP13	5.41e-04	379	179	9	EFO_0004995
Disease	pathological myopia	RNF135 TNIP1 ARAP3 PTPRD DNAH9	5.92e-04	111	179	5	EFO_0004207
Disease	muscular atrophy (biomarker_via_orthology)	NR3C1 TGIF1 TRIM63	7.14e-04	29	179	3	DOID:767 (biomarker_via_orthology)
Disease	lymphocyte percentage of leukocytes	ZBTB38 ATP13A1 OSER1 TNIP1 NR3C1 RUNX2 IQGAP1 NFATC1 TBC1D1 DNAI4 ZC3H7B MRTFA	7.93e-04	665	179	12	EFO_0007993
Disease	Ovarian Mucinous Adenocarcinoma	DAPK3 MAST2 TRRAP	8.71e-04	31	179	3	C1335167
Disease	FEV change measurement, fatty liver disease	UBE2J2 PNPLA3	1.00e-03	8	179	2	EFO_0005921, MONDO_0004790
Disease	birth weight, parental genotype effect measurement	ZBTB38 LCORL IQGAP1 ARAP3 SUPV3L1 AKAP13	1.16e-03	192	179	6	EFO_0004344, EFO_0005939
Disease	monocyte count	ILRUN CRYBG2 FN1 FXR2 CARMIL1 TRPS1 ASH1L OSER1 MLLT10 RUNX2 MAST2 LYST HIVEP3 TGIF1 ARVCF PLAG1 AKAP13 MRTFA	1.17e-03	1320	179	18	EFO_0005091
Disease	cognitive function measurement	TLK2 DMXL2 KCNH7 LCORL DSP ZNF618 PARD3B TNIP1 NR3C1 RNF214 SGCZ NEK3 ARAP3 PTPRD TBC1D1 DNAI4 MYO18B OGA MRTFA	1.19e-03	1434	179	19	EFO_0008354
Disease	pit and fissure surface dental caries	HIVEP2 PTPRD PIP5K1B	1.25e-03	35	179	3	EFO_0006338
Disease	gout	CARMIL1 RUNX2 OVOL1 PTPRD PNPLA3 ZNF518B	1.29e-03	196	179	6	EFO_0004274
Disease	colon cancer (is_implicated_in)	CHAF1A RICTOR PTPN13	1.35e-03	36	179	3	DOID:219 (is_implicated_in)
Disease	hair colour measurement	ZBTB38 ZNF618 TRPS1 RUNX2 LYST VPS9D1 OVOL1 NFATC1 PCNX1 AKAP13 CREB3L3	1.40e-03	615	179	11	EFO_0007822
Disease	gestational age	ZBTB38 ZNF385B HIVEP3 ANKRD44 PCNX1	1.57e-03	138	179	5	EFO_0005112
Disease	Pleural Diseases	TNC MSLN	1.59e-03	10	179	2	C0032226
Disease	systolic blood pressure, self reported educational attainment	CDC14A CDON	1.59e-03	10	179	2	EFO_0004784, EFO_0006335
Disease	cancer antigen 125 measurement	MUC16 MSLN	1.59e-03	10	179	2	EFO_0010603
Disease	body height at birth	ZBTB38 HIVEP2 LCORL	1.84e-03	40	179	3	EFO_0006784
Disease	blood urea nitrogen measurement	LCORL DAPK1 CDC14A OVOL1 NFATC1 PIP5K1B AKAP13 ZRANB1 PROX1	1.84e-03	452	179	9	EFO_0004741
Disease	fasting blood glucose measurement	ZBTB38 TRPS1 ARAP3 NFATC1 NOM1 PIP5K1B PROX1	1.92e-03	287	179	7	EFO_0004465
Disease	interleukin-6 measurement, response to stimulus	CARMIL1 MUC16	1.94e-03	11	179	2	EFO_0004810, GO_0050896
Disease	pulse pressure measurement	CDSN MXRA5 FN1 GOPC MAP1B LCORL ZNF618 CARMIL1 TRPS1 ZNF385B MAST2 SARNP HIVEP3 TGIF1 PTPRD ARVCF AKAP13 OBI1	2.09e-03	1392	179	18	EFO_0005763
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP2 HIVEP3	2.73e-03	13	179	2	DOID:0050787 (implicated_via_orthology)
Disease	sphingomyelin 18:1 measurement	MAP1B PARD3B	2.73e-03	13	179	2	EFO_0010394
Disease	visceral adipose tissue measurement	HIVEP2 LCORL CARMIL1 TRPS1 BACH1 PARD3B MAST2 HIVEP3 SGCZ	2.80e-03	481	179	9	EFO_0004765
Disease	hippocampal CA1 volume	SCFD2 DACT1 ZRANB1	3.11e-03	48	179	3	EFO_0009394
Disease	telomere length	CARMIL1 NOC3L TNIP1 TSPYL6 PITPNM1 HIVEP3 PARP1	3.11e-03	313	179	7	EFO_0004505
Disease	eosinophil percentage of granulocytes	TNIP1 IKZF4 HIVEP3 AKAP13 ZC3H7B DNMT3L	3.14e-03	234	179	6	EFO_0007996
Disease	membranous glomerulonephritis (biomarker_via_orthology)	A2M NPHS1	3.17e-03	14	179	2	DOID:10976 (biomarker_via_orthology)
Disease	developmental disorder of mental health (implicated_via_orthology)	GABRP ASH1L PARD3B	3.30e-03	49	179	3	DOID:0060037 (implicated_via_orthology)
Disease	balding measurement	SCFD2 CCDC91 ILRUN CRYBG2 ZBTB38 ZNF618 TRPS1 RUNX2 IQGAP1 VPS9D1 CLINT1 CDON	3.39e-03	792	179	12	EFO_0007825
Disease	Alopecia, Male Pattern	PARP1 SUPV3L1	3.65e-03	15	179	2	C4083212
Disease	mannan-binding lectin serine protease 1 measurement	ZNF385B FCN3	3.65e-03	15	179	2	EFO_0008223
Disease	Alobar Holoprosencephaly	TGIF1 CDON	3.65e-03	15	179	2	C0431363
Disease	Androgenetic Alopecia	PARP1 SUPV3L1	3.65e-03	15	179	2	C0162311
Disease	posterior thigh muscle volume	ZBTB38 LCORL	3.65e-03	15	179	2	EFO_0020931
Disease	Female pattern alopecia (disorder)	PARP1 SUPV3L1	3.65e-03	15	179	2	C0263477
Disease	type 2 diabetes mellitus (implicated_via_orthology)	NR3C1 PARP1 OGA CRTC2	3.89e-03	105	179	4	DOID:9352 (implicated_via_orthology)
Disease	decreased susceptibility to hepatitis C infection	PTPRD SH2D7	4.15e-03	16	179	2	EFO_0010101
Disease	Stevens-Johnson syndrome, toxic epidermal necrolysis, response to anticonvulsant	DDX12P NIPAL2	4.15e-03	16	179	2	EFO_0004276, EFO_0004775, GO_0036277
Disease	Lobar Holoprosencephaly	TGIF1 CDON	4.15e-03	16	179	2	C0431362
Disease	Semilobar Holoprosencephaly	TGIF1 CDON	4.15e-03	16	179	2	C0751617
Disease	filaggrin gene expression measurement	ZNF618 TRPS1	4.15e-03	16	179	2	EFO_0020899
Disease	neutrophil percentage of leukocytes	ZBTB38 ATP13A1 OSER1 NR3C1 IQGAP1 NFATC1 TBC1D1 AKAP13 ZC3H7B MRTFA	4.25e-03	610	179	10	EFO_0007990
Disease	vitamin D measurement	NPHS1 MIA3 CARMIL1 TRPS1 ASH1L MAST2 OVOL1	4.57e-03	336	179	7	EFO_0004631
Disease	cortical thickness, neuroimaging measurement	CCDC91 RUNX2 TMEM273 DACT1	4.59e-03	110	179	4	EFO_0004346, EFO_0004840
Disease	Holoprosencephaly	TGIF1 CDON	4.69e-03	17	179	2	C0079541
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TLK2 MED13	4.69e-03	17	179	2	DOID:0060307 (is_implicated_in)
Disease	testosterone measurement	SCFD2 ILRUN LIMA1 MIA3 LCORL FXR2 TRPS1 ZNF385B NR3C1 IQGAP1 DACT1 MSH6 OVOL1 NFATC1 PNPLA3 PROX1	4.89e-03	1275	179	16	EFO_0004908
Disease	skin aging measurement	LCORL RAB11FIP2 TRPS1 RUNX2 ZNF518B	5.04e-03	181	179	5	EFO_0008006
Disease	progression free survival, ovarian carcinoma	LCORL NBAS	5.25e-03	18	179	2	EFO_0001075, EFO_0004920
Disease	creatine kinase measurement	BACH1 ZRANB1 MRTFA	5.56e-03	59	179	3	EFO_0004534
Disease	neuroimaging measurement	SCFD2 CCDC91 MAP1B LCORL CARMIL1 CHAF1A TRPS1 MLLT10 RUNX2 TMEM273 DACT1 SNAP91 NIPAL2 CRTC2	5.80e-03	1069	179	14	EFO_0004346
Disease	retinal layer thickness measurement	NBAS PTPRD SNAP91	5.83e-03	60	179	3	EFO_0600002
Disease	kidney failure (biomarker_via_orthology)	NPHS1 PARP1	5.85e-03	19	179	2	DOID:1074 (biomarker_via_orthology)
Disease	Pseudopelade	PARP1 SUPV3L1	5.85e-03	19	179	2	C0086873
Disease	Alopecia	PARP1 SUPV3L1	5.85e-03	19	179	2	C0002170
Disease	attention deficit hyperactivity disorder	CCDC91 MAP1B TRPS1 PARD3B ANKRD44 SGCZ SETD5	6.04e-03	354	179	7	EFO_0003888

Protein segments in the cluster

Peptide	Gene	Start	Entry
AGELAGTLTFSKELP	ZNF385A	306	Q96PM9
GPKTDSTLSFDLTLQ	ADNP	541	Q9H2P0
LPTTDDFTGTSKHGL	ARSF	296	P54793
LSGASPFLGDTKQET	DAPK1	211	P53355
FGESQDLPLKSDLGT	BACH1	361	O14867
LGSDSEGFSRKSPSA	ASH1L	11	Q9NR48
FLSFVSTDKDGDPTG	LINC00242	36	Q5T6M2
LLQTGTEEGSLDPKS	ARAP3	61	Q8WWN8
GGFDDSTLPLVDKSL	ARVCF	866	O00192
TGLELLSFDSGNLSK	CRYBG3	756	Q68DQ2
DDFLSSILGSGDSLP	CREB3L3	61	Q68CJ9
KELTSLGFLESGSDP	DNMT3L	201	Q9UJW3
LGLRAGKPTASDDTS	ABL2	761	P42684
FKSLGSAQGTPSEIS	ADGRG4	3051	Q8IZF6
PSSEGSINKILSGLD	CDC14A	346	Q9UNH5
LGDASIAAPFTSKLS	ATP13A1	951	Q9HD20
STETKEGLEQALPSG	EPN3	431	Q9H201
SSLDGNKPAESSLAF	AKAP13	541	Q12802
SAPSIAKSGSLDSEL	AKAP13	2711	Q12802
SSDLLDLQPDFSSGG	SNAP91	346	O60641
EGASSESLLSVPGQK	DMXL2	926	Q8TDJ6
VDTGKATLTASPLGA	CHAF1A	941	Q13111
LLPGTLAKSIGTFSD	CDSN	26	Q15517
SSKGTPLLATEFRGL	DCLRE1B	486	Q9H816
EKETTFNSLLCPSGG	A2M	911	P01023
SGDVGKTLSALRSPD	IQGAP1	636	P46940
DSGTAESPSLLQDKG	RBM41	226	Q96IZ5
TLTAKDGGNPSLSTD	PCDHGA2	421	Q9Y5H1
EKSEPLLLSGDSVFS	PCDHGA12	786	O60330
SLLRGGSDDSSKDPI	PARP1	776	P09874
GTASETPLDDGASKL	GOPC	436	Q9HD26
EKLPEAADFGTTSSL	GRSF1	386	Q12849
KGPTDGGQSLEELSS	PARP3	241	Q9Y6F1
EKGLLGNDAAPSTSS	CACNA1F	1601	O60840
LGKFSEGTAGDSLSL	FCN3	211	O75636
LAEKSSGFETQSAPG	MUC16	1401	Q8WXI7
DSGLADKGTQLPITT	NPHS1	1021	O60500
DGGEPALSSTAKITI	PCDH20	716	Q8N6Y1
SGLKTANLTGTDSPE	PARD3B	326	Q8TEW8
TPLNGFSEGSKTDAT	MAP1B	1181	P46821
SSLKQILGDSFSPGS	MAP9	246	Q49MG5
PFSDKLGELSDKIGS	CLINT1	196	Q14677
ELSTSDSGGPIFKSP	LAMA3	2826	Q16787
IGPGQLSSSTFDSEK	LIMA1	236	Q9UHB6
GSPQEKSLDKAGSES	NCKAP5L	616	Q9HCH0
TKPSEDSLSGQKGDS	FXR2	631	P51116
DSLSGQKGDSVSKLP	FXR2	636	P51116
KASGLDFEETVPTSG	KCNH7	961	Q9NS40
SGLGLKEFATNLTES	PPFIA3	1051	O75145
TGLDFFKLEELTPSS	KIAA1109	1141	Q2LD37
SVSKSQPDGSGLLDV	LCORL	421	Q8N3X6
GNGSPLADSKEIFLT	CDCA8	216	Q53HL2
SADTGSGKTAAFLLP	DDX59	246	Q5T1V6
LPPEASEGSSSFLGK	ENDOD1	316	O94919
PLSGSKESLVENSGL	PCNX1	321	Q96RV3
TPGSSGDFIIRTSKL	OIT3	336	Q8WWZ8
LFSLEFGSPGETEDK	MUC19	56	Q7Z5P9
SKGLPSSSTFTLEEG	PIP5K1B	501	O14986
AEGLSTFPSFSLEKS	PNPLA3	466	Q9NST1
DGSEPAKTSLQTTGL	GPR153	231	Q6NV75
GSLGSSIKDEASLPD	MRTFB	621	Q9ULH7
TDSSLDLGDGVPVKS	NFATC1	321	O95644
GLSKSSQGSEFLEEP	OBI1	566	Q5W0B1
LSGASPFLGETKQET	DAPK3	211	O43293
KLSSKGSFADLGLEP	DDX28	121	Q9NUL7
GSPFQEEEGSALKTS	NES	1576	P48681
DLEFSSGSPGKETNE	NR3C1	196	P04150
SFLGGAPTEDLKALS	MSLN	506	Q13421
LLSSGFEIDTPDKFG	ANKRD44	391	Q8N8A2
SGSLKIPNRDSGIDS	FGD3	66	Q5JSP0
SDSIGLTPGEKSELA	MSH6	666	P52701
GFELTFKTADDPSLS	DDOST	71	P39656
EGGENISASPLTSKA	NBAS	1376	A2RRP1
DTGSTPSIGENDLKF	RICTOR	1171	Q6R327
FLKGPLSEETEASDS	NEK3	441	P51956
KVTLGDSPSGDLFTC	OVOL1	106	O14753
FPLLESGDSTLGSSK	NUTM1	841	Q86Y26
EAKTGADTTAAGPLF	PQBP1	226	O60828
LSLLKDFFTSGSPEE	OPA1	176	O60313
DSSSEKGNFSPLELD	ARHGAP29	181	Q52LW3
PKDTSFLGSDDIGNI	RGPD3	396	A6NKT7
NLKDPGGSEFDSISK	ILRUN	226	Q9H6K1
PALDFKSEGSSQSLE	DACT1	536	Q9NYF0
TDSKDSGELSSLPLG	E2F4	276	Q16254
SLFPLGLTDEKSNGT	CCDC91	101	Q7Z6B0
LSGASPFLGDTKQET	DAPK2	221	Q9UIK4
KTGLDSPTGIDFSDI	FN1	1446	P02751
NIILTGDSSPGFSKE	CRTC2	616	Q53ET0
GDSSPGFSKEIAAAL	CRTC2	621	Q53ET0
LFLDGNGSISDSLPS	BORA	196	Q6PGQ7
SEVLPSAGAFSKSEG	POLQ	1266	O75417
LNISDPSGEGTLSVK	CPAMD8	756	Q8IZJ3
LSEILSDPSDDTKGF	DSP	2401	P15924
SKRDGSETGLLSSFP	CDON	541	Q4KMG0
STPEISLFSEEGLKG	CRYBG2	1071	Q8N1P7
EKLLGSDIFTGEPSL	IL23A	101	Q9NPF7
SFLNSKAGEPDGESL	CDC42EP4	51	Q9H3Q1
FESPTGTGKSLSLIC	DDX12P	61	Q92771
KLFSGLSVSSEGPSQ	DLGAP5	621	Q15398
TKAAEGGLSSPEFSE	FAM98B	36	Q52LJ0
NKSLILPDSSFDGTE	LYST	1501	Q99698
GQSAPSLTAGLKELS	MAST2	146	Q6P0Q8
PSKLLTSQEGSLGSE	DNAI4	141	Q5VTH9
RSSGFISELPSEEGK	CARMIL1	966	Q5VZK9
FQLDASGEPTKTSLG	DNAH9	1641	Q9NYC9
AALKEGLSGDALSSP	SEC14L1	211	Q92503
PDSGTELGTLETKAA	COL5A3	326	P25940
SSGDSSLEKEFLGAP	IKZF4	61	Q9H2S9
LVDSSGSIGPENFSK	COL6A6	626	A6NMZ7
GRSDKLSLPGFENLT	GABRP	31	O00591
ASKRFESSSGLPGVD	PTPN13	436	Q12923
KVLAFTSIGDGPLSS	PTPRD	491	P23468
FPKTDLLLDSESQGS	NOC3L	656	Q8WTT2
SSAGLDLKDSGLESP	MINDY2	81	Q8NBR6
DSKPSLFSDRLSDLG	RUNX2	236	Q13950
KLGESSLSPSLDSLF	USP9X	1066	Q93008
PKDTSFLGSDDIGNI	RGPD4	396	Q7Z3J3
SGPDNELSILGKAFS	RNF135	161	Q8IUD6
GDVAKEFGITPSTLS	TIGD6	31	Q17RP2
SQGLDLLSSSTEKPG	SEZ6L	151	Q9BYH1
FGKELSAIGSDTTPL	SNX8	256	Q9Y5X2
LKPLSNKTATDDTGG	PLD5	516	Q8N7P1
TFVLAGSADSPELGK	SYNM	1426	O15061
GSADSPELGKLADSS	SYNM	1431	O15061
LEGSLDSKIGIPSTS	LARS2	366	Q15031
DSASVKSLDLPSIGG	SYNRG	806	Q9UMZ2
RFGISSVPTKGLSSD	SARNP	126	P82979
DQTDSTGGPAFLSKV	MIA3	706	Q5JRA6
GAALSGEPTTLTKEE	OGA	441	O60502
LPDGSDSTKSQSGEK	NIPAL2	366	Q9H841
SGSFSGKDRASPESL	PROX1	501	Q92786
ASSGGLPTDEITFAK	STS	106	P08842
ALGLEETSASAGLPK	SETSIP	31	P0DME0
EGPETLSSALSKGAT	SETD5	1216	Q9C0A6
SNSKDVLESGLSPGK	TRGV5	71	A0A0B4J1U4
LSSPADLAQFSKGSD	CCT8L1P	261	A6NM43
LSSPADLAQFSKGSD	CCT8L2	261	Q96SF2
KDGSSSVPLSFARDG	NOM1	201	Q5C9Z4
KLGSLGDVDSTTLTP	SCFD2	196	Q8WU76
ETIKLGNLPTGSFSS	SGCZ	241	Q96LD1
ETHKLLNLEGFPSGS	SUPV3L1	681	Q8IYB8
EDELTPGSKKSANGS	MED13	791	Q9UHV7
NGISKGADSELSTVP	NOP2	651	P46087
SGVPVSKELLTAGSD	NOPCHAP1	21	Q8N5I9
LGISSPKEFSAGESS	OSER1	121	Q9NX31
DFLESSTGLPLLTSG	MRTFA	816	Q969V6
FRKVLDGLTASSPGS	STXBP5L	6	Q9Y2K9
LEDFLDKSASGPGLA	SLC6A18	371	Q96N87
SSGNTELKDTAPALG	TLK2	376	Q86UE8
KSFENSPGDLGNSSL	MLLT10	431	P55197
ASEGPLIDKGLAQSS	ANGEL1	76	Q9UNK9
SLENGGPSSLESKSE	CLUH	641	O75153
SLDEPGGATFLLTAK	TRIM63	266	Q969Q1
ASSSSKLGLDPQIGS	PLAG1	376	Q6DJT9
DIPLDLSSSAGSGKR	TGIF1	151	Q15583
GSFDPLAELTGKDSN	TNIP1	81	Q15025
KFPLGDGSSLLLADT	PITPNM1	761	O00562
EFLTAGKETAPSLGS	UCP1	101	P25874
KSDEGLPDGLSTKDS	RNF214	26	Q8ND24
GFKLQPELSTISEDG	VWDE	291	Q8N2E2
KSIPALQSSDSGDLG	TRPS1	381	Q9UHF7
RLSLGDFASDKAGSP	USP21	486	Q9UK80
GLAKETFGSLEETSP	ZNF618	676	Q5T7W0
GPTLGSIETSDFTKR	UBE2J2	126	Q8N2K1
EALPISESSFKLLGS	TBC1D1	551	Q86TI0
SGKLLDPQEFTLSGT	TNC	1566	P24821
DEQAFLSPGSKGSTE	HIVEP3	376	Q5T1R4
KSSSLLEESFGGPSD	SH2D7	226	A6NKC9
LDSFGTVPESGSLKS	RAB11FIP2	256	Q7L804
QPSSSESGSFLLKSG	ZNF385B	236	Q569K4
GTPSVAGSENLLKTD	RALGAPB	46	Q86X10
PSKSGSLLDSDNFIG	SERINC3	326	Q13530
SSDILGKESEGSRSP	MYO18B	101	Q8IUG5
GEKSGLNSSLFSSPV	ZNF180	196	Q9UJW8
SSCVDSFGSPLGLDK	ZNF644	611	Q9H582
TTDGSLKNGFPGEET	TSPYL6	106	Q8N831
KALTTGSLPTFIDAG	PIGO	136	Q8TEQ8
LLTSSALLSEPDFGG	TASOR2	131	Q5VWN6
ADPGGSLSKTTNIAE	ZBTB38	796	Q8NAP3
LGDTASGLPDKDSSF	VPS9D1	366	Q9Y2B5
ASEPKDGLQSGSSSF	HIVEP2	1501	P31629
DDSSDLKSTPGGLSD	TMEM273	66	Q5T292
SGSELTAKLEPAFLS	TRRAP	2431	Q9Y4A5
LEPDATGTSKGIEFT	SON	1601	P18583
TLAALLSPKESSGGE	SON	1691	P18583
SDKATSPLSLDAGLG	TRPM4	541	Q8TD43
IITEDPFKSGSSDVG	ZRANB1	36	Q9UGI0
AGSKRTPELLGSAES	ZNF541	1271	Q9H0D2
ALDSFGSTRGSLDKP	ZC3H7B	361	Q9UGR2
TCSFSGEKGLLPVSE	ZNF518B	536	Q9C0D4
TGLQKPLSSAFDGVS	BPIFA4P	51	Q86YQ2
TEGDLKGTAAPTLIS	MXRA5	901	Q9NR99
STSSADLSGLGAEPK	PPP1R9A	931	Q9ULJ8